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There is little is known about the effects of different types of exercise and the release of extracellular 
vesicles (EVs) during exercise into the circulatory blood system. Also, there is a paucity of 
published data on the relationship between different modalities and types of exercise and the 
secretions of inflammatory cytokines into the circulatory blood system. Moreover, although it is 
becoming increasingly evident that a physically active lifestyle is associated with lower 
concentration levels of inflammatory markers, many studies have researched only leisure-time 
physical activity and have not investigated whether different modalities and  eccentric exercise as 
compared to moderate intensity concentric cycling exercise may be associated with changes in 
inflammatory marker concentrations. Therefore, this study aims to measure the content of 
extracellular vesicles levels in resting healthy male individuals and then to use this information to 
investigate the systemic concentration levels of EVs and inflammatory cytokines in response to 
eccentric exercise in healthy individuals. 
 
Methods 
Eleven healthy male individuals were eligible and participated in this study. In order to measure 
perceptual responses to exercise level and to provide a valuable and reliable indicator of exercise 
tolerance, Rate of Perceived Exertion (RPE) scale was used as the subjective measure in this study. 
The variation in the concentration levels of extracellular vesicles and also of inflammatory 
cytokines (IL-6, TNF-α, IL-10) were assessed during resting and in response to a single bout of 




examined the variability and content of plasma EVs concentration levels within and between 
subjects.  
EVs were prepared and isolated, and Nanoparticle Tracking Analysis (NTA) was then used to assess 
EV concentration levels and vesicle sizes. A mouse muscle cell line (C2C12) model was used to 
explore the effect of exercise on EVs concentration levels. As a measure of changes in 
differentiation of muscle cells the expression level of Myogenin in EV-treated C2C12 cells by 
plasma samples was determined by qPCR. The experimental conditions and cell model for the 
differentiation of C2C12 was standardised and the expression of muscle differentiation gene 
markers was analysed by quantitative real time Reverse Transcription-Polymerase Chain Reaction. 
The effect of plasma EVs on C2C12 myoblast differentiation was also explored. 
 
Results 
This study suggests that exercise triggers a release into the circulatory blood system of vesicles with 
the characteristic size of EVs. It was found that there is a significant difference between the average   
EV concentration levels during the first three hours of rest and after eccentric exercise p<0.05, and 
that there was a reduction in the average EV concentration levels after two hours following eccentric 
exercise p<0.05. There was a trend for a reduction in myogenin in all treated plasma samples at the 
time point t=27 h, but the difference was not significant p> 0.05. Contrary to our hypothesis our 








It is hypothesised that that the reduced EV after exercise  may be because EVs are taken in by 
muscles and become involved in the recovery process from the damage caused by eccentric 
exercise. However, the mechanism of the secretion and uptake remains to be clarified. The 
consistent reduction in myogenin in all the samples may point to potential clinical significance. In 
order to more fully understand the role of EVs in muscle cell differentiation, further studies need to 
be conducted.   
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It has been reported that physical activity has an impact on physiological parameters such as heart 
rate, blood pressure, respiratory rate, lactate levels, and the inflammatory response of the secretion 
of cytokines and extracellular vesicles amongst other things (Walsh et al., 2011). Regular exercise 
helps in the process of long-term adaptation in muscle metabolism and in the regulation of the 
cardiovascular system, and it also has a modulating effect on the immune system (Breitbach, Tug, 
and Simon 2012; Egan and Zierath, 2013). Extracellular vesicles (EVs) are membrane vesicles 
that are released by various cells into the extracellular environment, and they play an important 
role in intercellular communication between cells (Raposo and Stoorvogel, 2013). EVs (of 30-
120nm in diameter) that are known to play many roles in human physiology and pathology (Théry 
et al., 2002).  
Cytokines and EVs  are released into the circulatory blood system during exercise, and the effect 
of different exercise protocols on circulating cytokines and EVs has been reported in different 
studies (Frühbeis et al., 2015). There is an association between exercise and the secretion of 
cytokines, and it is suggested that EVs play an important role in immune modulation (Zhang et 
al., 2016) causing a reduced level of inflammation as one of the benefits of exercise. Randomised 
control studies of aerobic physical activity have concluded that regular aerobic exercise decreases 
chronic inflammation and decreases the expression of inflammatory markers in skeletal muscles 
(Campbell et al., 2009; Fairey, 2005; Nicklas, 2008). However, although it is becoming 
increasingly evident that a physically active lifestyle is associated with the secretion of lower 
levels of inflammatory markers, many studies have examined the anti-inflammatory response only 
with regard to leisure-time physical activity (Friedenreich, 2011; Il'yasova et al., 2005), and have 
not investigated whether or not different modalities and intensities of physical activity may be 
associated with changes in inflammatory marker secretion levels. The level of exercise undertaken 
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is a key determinant of the benefit related to exercise, and it is thus important to understand the 
relationship of different types of exercise with the secretion of EVs into the circulatory blood 
system.   
The intention of this study is to explore the content of the resting concentration levels of these 
EVs in human plasma (cf. Chapter 3), and then to explore the correlation between different types 
of exercise and their effect on cytokine and EV secretions (cf. Chapter 4). In this study, in the 
context of exercise and the systemic effect of EVs on muscle development, the discussion about 
the secretion of EVs in response to exercise will be explored. In addition, Chapter 1 will provide 
an overview of the published literature on the importance, benefit, and effect of exercise on the 
human body, and of the effect of exercise on EV secretion.  
 
1.2 What is physical activity? 
Physical activity has been defined in many ways. Generally, physical activity is considered to be 
any action or movement of the body that results in the working of the muscles, and the 
consumption of more energy than when compared to the resting (Westerterp, 2013). Some 
examples of physical activity include running, walking, yoga, swimming, and dancing. According 
to the World Health Organisation (in its publicity material on its website), physical activity is 
defined as any bodily movement produced by skeletal muscles that need energy expenditure, while 
exercise refers to a type of physical activity that is planned, structured, repetitive, and purposeful 
in the sense that the improvement or maintenance of one or more components of physical fitness 
is the objective. According to the available literature, the main recommendations of physical 
activity for health and wellbeing can be categorised as either aerobic or resistance exercise 
(Westerterp, 2013). Aerobic exercise is any activity that depends on oxygen to consume energy, 
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increases heart rate, and involves several large muscle movements, while resistance exercise relies 
on the use of weights, machines, or body resistance to train muscles.  
The level and duration of physical activity are major factors in the determination of the expression 
profile of cytokines (Nieman and Pedersen, 1999). Work rate (or power) is defined as the function 
of force and velocity during exercise (Enoka, 2002) and it describes the amount of work achieved 
per unit of time. The level of the work rate can be manipulated by changing the amount of exercise 
performed within a specific time, or by altering the time to produce a specific volume of exercise. 
Exercise level and duration are inversely related: the higher the exercise level, the shorter the 
duration that the exercise can be sustained (Heyward and Gibson, 2014). The level of the work 
rate reflects the compliance and integrity of physiological, neurological and perceptive 
mechanisms that control human movement and performance. However, exercise level can be 
described in absolute terms such as heart rate (HR), power output (watts), and blood lactate levels 
(BLa), or as energy expenditure in terms of calories, and as a subjective measure such as the rating 
of perceived exertion (RPE) (Heyward and Gibson, 2014). 
Measures of blood lactate concentration levels are generally used as a means of calculating 
metabolic responses to the level of exercise. The use of blood lactate concentration levels is based 
on the accumulation of lactate in muscles which have been stimulated by exercise. The increase 
in blood lactate concentrations can occur either due to an elevation in lactic acid production, or a 
reduction in lactic acid removal (Powers and Howley, 2004). However, there is considerable 
debate surrounding the precise mechanism that leads to an increase in blood lactate levels. 
Although lactate accumulation is not a causative factor of fatigue, blood lactate level is a useful 
tool for assessing the performance of exercise (Shimojo et al., 1993), and the Lactate Pro® analyser 
has been shown to be a reliable method of measuring blood lactate concentration levels (Shimojo 
et al., 1993). 
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The intensity of exercise is a key determinant of the benefit related to exercise. For example, an 
improvement in the health of patients with cardiovascular disease has been associated with low-
intensity exercise training viz. exercise at less than 45% of maximum aerobic power (Blumenthal 
et al., 1988). Warburton et al. (2006) clearly state that regular physical activity is effective in the 
secondary prevention of cardiovascular disease and in attenuating the risk of premature death. 
The term high intensity exercise can include both eccentric and concentric activity , but Herzog 
et al. (2008) said that if a skeletal muscle contracts isometrically, then a force that is relative to 
the final isometric sarcomere length (SL) is produced.  However, when a muscle is stretched 
during a contraction, i.e. eccentric contraction, the same final SL is achieved at a relatively higher 
force. This phenomenon is referred to as residual force enhancement. Herzog et al. (2015) added 
that muscle contraction was originally believed to be controlled exclusively by the contractile 
filaments, actin, and myosin. Eccentric contractions are associated with a force that was not 
assigned to just actin and myosin but associated to filamentous protein titin.  
Eccentric exercise is considered to be an initiator of the stress physical response (Nehlsen-
Cannarella, 1998), and experiments in senescent animals subjected to exercise training 
(Hammeren et al., 1992), show increases in antioxidant mechanisms (Moran, 2004) and in 
hypertrophy induction (Narici et al., 2004). Other researchers have highlighted the importance of 
different parameters of exercise depending on different muscular types and have reported either 
increases in oxidative capacity (Silbermann et al., 1983), muscle weight (Wernig et al., 1990), the 
number and size of mitochondria (Howald et al., 1985), and an altered distribution of muscle fibre 
types (Kovanen and Suominen, 1987). 
Excessive workouts are tantamount to physical stress that is equivalent to clinical physical stress 
caused by sepsis, burns, trauma, and surgery (Natale et al., 2003). Pedersen and Hoffman-Goetz 
(2000) claim that exercise can cause a cascade of immunological responses and hormonal changes 
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that is similar to that caused by clinical physical stress, and that cytokines are usually expressed 
and released in response to infectivity, injuries, or inflammation of tissue. These cytokines 
facilitate an incursion of B cells, T cells, monocytes, and neutrophils that contribute to the clearing 
of the antigen and hence prepare for the healing of tissue (Pedersen and Hoffman-Goetz, 2000). 
 
1.2.1 Why is physical activity important? 
There are a number of benefits of a physically active lifestyle that are well described in the 
scientific literature. Importantly, regular physical activity reduces the risk related to coronary heart 
disease and stroke, diabetes, hypertension, colon cancer, breast cancer, and depression (WHO, 
2010). Physical inactivity is recognised as the fourth major risk factor for global mortality with 
an estimated 3.2 million deaths globally (WHO, 2016), and it is thought to be responsible for 6% 
of the burden of disease (Lee et al., 2012). The benefits of regular exercise include both 
preventative and therapeutic aspects of different diseases such as obesity, hypertension, 
dyslipidaemia, diabetes mellitus, cardiovascular disorders, muscle, bone and joint diseases, 
pulmonary diseases, cancer, and depression (Warburton et al., 2006). 
Physical activity is associated with a reduced risk of non-communicable diseases and many 
plausible mechanisms have been suggested to account for this risk reduction (Gleeson et al., 2011; 
Tiernan et al., 2008). The duration of exercise, frequency, and environmental conditions play a 
major role in the physiological benefits of exercise. Intense exercise results in chemical, 
mechanical, and thermal changes to meet the increased physical demands that result in 
amendments to metabolic, cardiovascular and ventilatory function (Burton et al., 2004). The key 
role of red blood cells is to transport respiratory gases (O2 and CO2) from the lungs to body tissues 
and from tissues back to the lungs for expiration. The increase in O2 demand during the exercise 
of skeletal muscles is matched by an increase in muscle blood flow caused by increasing cardiac 
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output, the modulation of blood flow among the vital and inactive organs, and by optimisation of 
microcirculation (Laughlin et al., 2012). Exercise increases the total haemoglobin mass by 
stimulating erythropoiesis, and this increases the production of red blood cells, which in turn 
increases the amount of O2 that can be transported by blood (Mairbäurl, 2007). 
Eccentric exercise produces significant benefits (Gregg et al., 2003; Brown et al., 2002; Middleton 
et al., 2007) and such physical activity ensures several long and short-term benefits both in 
childhood and in adolescence (Dias et al., 2016). Physical activity not only reduces the risk factors 
for the development of hypertension (Leary et al., 2008) and dyslipidaemia (Jago et al., 2008), 
but extensive physical activity is accompanied by a reduced risk of the development of excess 
adipose tissue (Ness et al., 2007). Brodersen et al. (2007) note that in Western societies physical 
activity is declining and sedentary lifestyles are becoming more common for all age groups, but 
especially in children aged 10-12. Their conclusion therefore was that, in order to stop the trend 
towards obesity and other poor health conditions resulting from a sedentary lifestyle, there needs 
to be an increase in physical activity by all the different age groups in a population. 
Physical activity increases muscle mass and strength, as well as decreasing fatigability as a result 
of changes in muscle metabolism (Rimmer et al., 2012). Physical activity enhances the ability of 
muscles to resist fatigue in people of all ages (Bishop et al., 2011). Mechanical forces relating to 
physical activity (so-called ‘impact’ exercises) result in forces that lead to maintenance of or the 
gaining of bone mass (Vieira et al., 2013; Moreira et al., 2013; and Moreira et al., 2014). In 
addition, a study conducted by Yaffe et al. (2001) on the correlation of physical activity and 
cognitive decline concluded that women with greater levels of baseline physical activity were less 
prone to developing cognitive disabilities, and those suffering from any diagnosed disability were 
able to improve their mental health and show greater resilience with an appropriate change in their 
life style.  
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There are several possible mechanisms that are directly influenced by physical activity, and these 
include, but are not limited to, the reduction of the risk of cardiovascular and cerebrovascular 
diseases (Blumenthal et al., 1988), increasing blood flow to the brain (Basso and Suzuki, 2017), 
and stimulating neuronal growth (Van Praag et al., 1999). 
 
1.2.2 Cardiovascular, respiratory, and metabolic responses to exercise 
 
The regulation and circulation of blood flow has been intensively investigated, and it is evident 
that the mechanisms controlling the heart play a role in (1) providing muscles that are being 
exercised with a sufficient level of blood and also ensuring adequate metabolic washout of end-
products; and (2) regulating arterial blood pressure to provide sufficient perfusion in the main 
organs without increased pressure differences among them (Ichinose et al., 2014). 
 
The association between the oxygen demand of exercising muscles and the beating heart is 
obvious because of the fact that during physical activity, output of the heart increases linearly to 
address O2 uptake (Faulkner et al., 1977). The increase in heart output is induced by an increase 
in heart rate and stroke volume, both of which act against the reduction in systemic vascular 
resistance through a flow-increment mechanism. Furthermore, exercise that targets large muscles, 
e.g. cycling and swimming, leads to significant vasodilatation in the muscle vasculature, thus 
decreasing systemic vascular resistance. This represents a big challenge for the heart because it 
would need lead to a decrease in blood pressure, inhibiting brain and muscle perfusion. Dynamic 
physical activity leads to a small increase in mean arterial pressure while isometric physical 
activity causes a sharp increase in mean arterial pressure. This small increment in mean arterial 
pressure during dynamic physical activity occurs despite the significant decrease in the systemic 
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vascular resistance due to the muscle vasodilatation (Lewis et al., 1983). The skeletal muscle 
produces many putative vasodilators during contractions, including potassium, adenosine, 
hydrogen ions, carbon dioxide, and phosphates. Exercise induces sheer stress which triggers the 
endothelial function to produce Nitric Oxide which works as a vasodilator to deliver more blood 
from the heart to the muscle that is being exercised (Nakano et al., 2000).  
It is a well-known fact that cardiovascular responses are controlled by mechanical mechanisms 
(skeletal muscles and lung pumps), which drive blood towards the heart, thereby improving its 
preload and stroke volume, and by nervous mechanisms, which control the vagal tone and flow to 
satisfy the metabolic need of muscles during exercise. 
The respiratory and skeletal muscle pumps lead to an increase in cardiac output and stroke volume 
during dynamic exercise. Compared with the respiratory pump, the skeletal muscle pump has the 
most significant role since the muscle rhythmic contractions happening during dynamic exercise 
lead to intramuscular oscillations which support blood flow to the cardiovascular apparatus and 
improve heart preload, thereby improving stroke volume via the Frank-Starling mechanism 
(Higginbotham et al., 1986). 
Exercise triggers parasympathetic withdrawal and sympathetic activation, which depend on 
exercise level and the muscle mass exercising (Nakano et al., 2000). The role of parasympathetic 
withdrawal is to increase heart rate, and the sympathetic activity works on increasing heart rate, 
at improving myocardial contractility to enhance stroke volume, at triggering venoconstriction to 
promote venous return, at increasing vascular resistance in the abdominal viscera and resting 
skeletal muscles, and at maintaining the available heart output for the perfusion of the muscle 
exercising, where metabolic-mediated vasodilation occurs. 
Central and peripheral mechanisms are needed for normal physiological functions. In the central 
mechanism, the activation of parts of the brain trigger the heart control regions in the medulla. 
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Haemodynamic status is regulated by the nervous system during physical activity through signals 
initiated by the brain and the periphery (exercise pressor reflex, baroreflexes, and arterial 
chemoreflex) (Higginbotham et al., 1986). 
 
1.2.3 The effect of exercise modality and level of eccentric exercise on the inflammatory 
response 
Inflammation is associated with a number of non-communicable diseases such as rheumatoid 
arthritis, hypertension, heart diseases, and cancer. Inflammation is also related to increased risk 
of obesity in children (Fröhlich et al., 2000; Straczkowski et al., 2001), and it has been suggested 
that both inflammation and hyper-coagulable status are related, probably through modifications 
in metabolic control, to the production of higher levels of reactive oxygen and the development 
of chronic but low-grade inflammation (Franceschi and Campisi, 2014).  
Gleeson et al. (2011) and Friedenreich (2011) proposed that physical activity affects adipokines 
and inflammatory markers such as the viscosity of plasma, erythrocyte sedimentation rate which 
helps to detect the inflammation associated with diseases such as cancer, and C-Reactive Protein 
(CRP) which is secreted by the liver in response to cytokines, and Petersen and Pedersen (2005) 
state that chronic inflammation is characterised by elevated blood levels of proteins and cytokines 
including CRP, Tumour Necrosis Factor-α (TNF-α), and Interleukin-6 (IL-6).  
Although it is becoming increasingly evident that a physically active lifestyle is associated with 
lower concentrations of inflammatory markers, many research papers have assessed only leisure-
time physical activity (Friedenreich, 2011; Il'yasova et al., 2005), and have not investigated 
whether different modalities and levels of physical activity may be associated with changes in 
inflammatory marker concentration levels. According to the Encyclopaedia of Public Health, 
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leisure time physical activity refers to exercises or sports that are performed at the discretion of 
the person. Hence, there is a distinction between it and physical activity which is engaged in as 
part of gainful employment or an essential activity of daily living. 
Intense eccentric exercise acutely impairs the cellular immune system and causes inflammation, 
and Pedersen and Toft (2000) state that strenuous exercise can increase the concentration levels 
of IL-6 by as much as 100-fold, and that TNF-α levels increase by a factor of 2 to 3. The 
concentration levels of IL-6 peak with the cessation of exercise, but the levels of IL-1ra do not 
rise until the exercise has ceased and peak about 2 hours after exercise has ceased. Strenuous 
exercises vigorous activities are normally performed by athletes, and they include swimming laps, 
running in marathons, and basketball.  
 
Figure 1: The production of cytokines in response to strenuous exercise (from Pedersen and 
Toft, 2000). Interleukin-6 (IL-6), Interleukin-1 receptor antagonist (IL-1ra), Interleukin-8 (IL-8), 
Macrophage inflammatory protein 1  (MIP-1), Soluble tumour necrosis factor- receptor 
(sTNF-R) Tumour necrosis factor R), Interleukin-1 (IL-1). 
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Bruunsgaard et al. (1997) found a correlation between muscle damage and increased 
concentration levels of IL-6 and found IL-6 in the biopsies of skeletal muscles, whereas IL-1ra 
mRNA was expressed by blood mononuclear cells. They therefore concluded that the production 
of IL-6 is produced in response to tissue injury and to infections. 
Findings from experimental studies designed to assess the effects of physical activity on 
inflammation and inflammation markers show less significant and consistent results than the 
results obtained from observational studies. This might be due to publication bias, differences in 
energy expenditure and differences in modalities (aerobic vs. resistance), level and duration of 
physical activities used in studies, and lack of appropriate control groups in randomised control 
trials. In the text that follows, a summary of some studies on the effect of different modalities and 
intensities of physical activity on inflammation is provided.  
 
Figure 2: The release of myokines by exercise-induced muscle contraction from So et al. (2014). 
Interleukin-15 (IL-15), Leukaemia Inhibitory factor (LIF), Brain-Derived Neurotrophic Factor 
(BDNF), Fibroblast Growth Factor-21 (FGF-21) 
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1.2.3.1 The findings of Experimental Studies on the response to the inflammation system 
to exercise 
Acute inflammation starts immediately after a specific injury, and usually lasts for a short period 
of time. It promotes the migration of neutrophils and macrophages to the area of inflammation 
and stimulates the production of a whole range of cytokines such as IL-1, TNF-α, IL-6, and IL-
11, whereas chronic inflammation tends to stimulate IL-3, IL-4. IL-5, IL-7, IL-9 (Feghali and 
Wright, 1997).  Randomised control studies of aerobic physical activity have concluded that 
regular aerobic exercise decreases chronic inflammation and decreases the expression of 
inflammatory markers in skeletal muscles (Campbell et al., 2009; Fairey, 2005; Nicklas, 2008). 
For instance, Gielen et al. (2003) randomly selected and recruited twenty male patients with 
chronic heart disease to assess the effects of aerobic physical activity on inflammatory parameters. 
They found that regular aerobic physical activity was associated with diminished levels of 
microRNA, TNF-α, IL-1β, and IL-6 in skeletal muscles. To assess changes in circulating 
microRNA (miRNA) (non-coding RNA molecules of about 20-25 nucleotides in length) in 
response to acute and chronic aerobic exercise, eleven healthy young men participated in Aoi et 
al.’s (2013) study and performed a single bout of steady-state cycling (acute aerobic physical 
activity) for 60 min and cycling training (an aerobic physical activity) for three days a week for 
one month. Blood samples were collected before and after the exercises, and the levels of miRNAs 
were measured and it was found that miR-486 was significantly decreased by both acute and 
chronic cycling.  
Although more studies have been conducted on the influence of aerobic physical activity on 
inflammation, some studies used resistance physical activity to assess inflammation response with 
most of the findings being negative. The first published study was conducted by Rall et al. in 
1996, and they found that three months’ worth of high-level eccentric exercise did not reduce IL-
 
14  
1β, TNF-α, IL-6, or IL-2 production. Similarly, McFarlin et al. (2004) also reported that there was 
no significant association between the level of inflammatory cytokine expression (IL-6, TNF-α) 
and resistance training in women between 65 and 80 years of age, compared with untrained 
women (control group). However, the null effect of these two trials may be due to the small 
number of participants (6-8) in the intervention groups; but, in 2009, Levinger et al. conducted a 
larger randomised clinical trial in which 56 middle-aged women and men undertook resistance 
physical activity for almost three months, and their finding also was that this did not significantly 
decrease IL-6 or CRP expression.  
However, in contrast to these negative results, Brooks et al. (2007) found that a four-month 
resistance physical activity trial reduced CRP and increased adiponectin expression among people 
with Type 2 diabetes. One year later, Lambert et al. (2008) asserted that the coupling of resistance 
physical activity with aerobic physical activity reduced concentrations of IL-6 and TNF-α. These 
results were similar to those of Brochu et al. (2009) who found that resistance physical activity 
alone did not improve inflammatory markers among participants in their study, but when 
combined with weight loss, significant improvements in markers were in fact noticed. Similarly, 
a noticeable decrease in TNF-α mRNA and protein levels in skeletal muscle were reported after 
resistance training among older men and women (Greiwe et al., 2001). In conclusion, there 
appears to be considerable evidence that aerobic physical activity interventions are useful for 
reducing levels of inflammatory markers, and cytokines, both locally in skeletal muscle and 
systemically in the circulatory blood system.  
Many studies such as Moldoveanu et al. (2001) have concluded that acute periods of intense or 
prolonged physical activity can lead to biochemical changes that contribute to improvements in 
inflammatory response, but less is known about the impact of regular physical activity on the 
concentrations of inflammatory markers. Four trials (Mattusch et al., 2000; Smith et al., 1999; 
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Straczkowski et al., 2001; Tsukui et al., 2000) found that regular physical activity of various 
durations and intensities reduced levels of TNF-α and CRP in younger individuals. Moreover, 
many cross-sectional studies (Geffken et al., 2001; Ford, 2002; Taaffe et al., 2000) concluded that 
the regular performance of physical activity or fitness is associated with lower blood 
concentrations of IL-6 and CRP in different age groups. 
It has also been shown by Gleeson (2004) that nutrient intake alters immune response at rest and 
during exercise through direct or indirect mechanisms. In Gleeson’s study, all the subjects were 
asked to perform eccentric exercise after an overnight fast. They were then asked to consume 
carbohydrates after the exercise, and it was shown that plasma IL-6 and cortisol concentrations 
then increased significantly after exercise during the fasting state. However, there was a reduction 
in IL-6 and cortisol concentration after the consumption of the carbohydrate. 
The performance of eccentric exercises results in the secretion of IL-6 and has been associated 
with muscle damage (Petersen et al., 2001). However, a study by Croisier et al. (1999) did not 
show any such association between exercise-induced muscle damage and IL-6 levels, leading to 
speculation that the release of myokine is associated mainly with contraction of muscle fibres in 
order to mobilize substrate from fuel depots so that glucose homeostasis is maintained during 
intense physical activity. 
Croisier et al. (1999) concluded that there was a 6-fold increase in IL-6 concentration levels 
immediately after exercise and an 8-fold increase half an hour post-exercise which then returned 
to baseline levels a few days after the exercise. In their study, the authors used an exercise that 
involved greater use of musculature than in Petersen et al.’s ( 2001) study because they used two-
legged eccentrically based exercise of the knee flexors and extensors in their intervention. 
Pedersen et al. (2001) argued that the big and immediate increase in IL-6 levels after long-duration 
exercise is not related to muscle damage, but muscle damage itself is affected by repair 
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mechanisms such as the invasion of macrophages into the muscle leading to an increase in IL-6 
levels. IL-6 generation in relation to muscle damage happens later and is of a smaller scale than 
IL-6 generation related to muscle contractions (Pedersen et al., 2001).  
Febbraio and Pedersen (2002) argued that increases in the level of IL-6 were found to be 
associated with muscle contraction. In support, Ostrowski et al. (1999) hypothesised that 
inflammatory cytokines were produced in skeletal muscles in response to long-term exercise such 
as a marathon race. Additionally, elevated IL-6 and IL-1Ra levels have also been recorded in rats 
(Jonsdottir, 2000). Cytokine production is therefore not concurrent with tissue damage. However, 
IL-6 is expressed after muscle exercise.  
To conclude, IL-6 is the most expressed cytokine during exercise, and it is produced in skeletal 
muscles. It has been established that IL-6 is produced without muscle damage in eccentric 
exercises, and it has been reported that the level of that exercise is strongly correlated to the time 
and duration of the exercise (Rippe, 2011). Among participants who perform high- and low-level 
eccentric exercises, the level of IL-6 is greater with eccentric exercise than the level seen in low-
level eccentric exercise of the same duration (Cullen et al., 2016). Schäfer and Stein (2003) 
reported that it is still unclear whether low level eccentric exercise would produce a similar pattern 
of cytokines as eccentric exercise, and there is a lack of sufficient evidence on this in the published 
literature. Schäfer and Stein (2003) point out the need for more clinical trials to assess definitively 
the effects of different intensities and durations of exercise on inflammation markers.  
 
1.3 Extracellular vesicles 
Philip Stahl, in the introductory lecture that he gives on ‘Extracellular Vesicles’ at the University 
of California, Irvine says that the existence of membrane fragments and vesicles shed from the 
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surface of cells by selective blebbing and found in extracellular fluids has been known since the 
Second World War, and they are given the generic name of Extracellular Vesicles, this being a 
generic term including microvesicles, microparticles, ectosomes, oncosomes, prostasomes, and 
many other (entities). Extracellular vesicles (EVs) are membrane-contained vesicles released by 
prokaryotes, higher eukaryotes and plants (Figure 3); but, Doyle & Wang (2019) suggest that EVs 
are lipid bound vesicles secreted by cells into the extracellular space, and that the three main sub-
types of EVs are micro-vesicles and apoptotic bodies, whilst Edgar (2016) said that extracellular 
vesicles are released from cells upon fusion of an intermediate endocytic compartment, the 









EVs were first observed in 1946 by Chargaff and West (1946) and named as ‘platelet dust’ by 
Wolf (1967) because they were thought to contain nothing but biological debris (Kowal et al., 
2014). EV observation occurred simultaneously in various physiological settings indicating that 
this form of function or communication is a universally shared cell biological property (Yáñez-
Mó et al., 2015).  
EVs can be isolated by centrifugation to separate particles of large size, and then by 
ultracentrifugation at 100,000g for >1 hour (Whitham et al., 2018). EVs can also be isolated by 
other procedures such as gel filtration or by ultracentrifugation followed by size exclusion 
chromatography (Benedikter et al., 2017).  
 
Every ‘discovery’ in science is preceded by advances made by earlier generations of scientists,  
and the pioneering work that led to formulation of the current thinking on EVs was done on 
membrane trafficking by the Nobel Laureate Christian de Duve in the 1950s who pioneered the 





Figure 4: the development of an endosome leading to the release of an EV with  the support of 
Endosomal Sorting Complexes Required for Transport (ESCRT) viz. ESCRT I, and II (for 
membrane budding), and III (to complete the budding), and by Alg2-interacting protein X (ALIX) 
as described by Petiot et al. (2008), while the role of Tetraspanin-Enriched Microdomains (TEMs) 
has been described by Pols & Klumperman (2009). 
 
de Duve’s work culminated in 1983 in two ground-breaking papers on the role of transferrin 
binding to clathrin coated membrane-surface pits, the first by Pan and Johnstone (Johnstone et al., 
1983 and 1987) who, apparently in 1983, coined the term extracellular vesicles to describe 
secreted membrane vesicles derived from multivesicular bodies (MVBs), and the second by 
Harding, Heuser and Stahl (1983 and 2013). Less publicised, but also in 1983 is the work by 
Dautry-Varsat on human hepato-cellular carcinoma HepG2 cells (1983), and Klausner on the 
leukaemia cell line K562 (1983). Following that, work was done by many others, including Théry 
(1999) in the 1990s.  
However, as is the case at the beginning of all sciences, the names given to EVs were initially not 
standardised, and the nomenclature included the liberal use of terms such as extracellular vesicles 
(EVs), endosomes, microvesicles, retrovirus like particles (RLPs), apoptotic bodies, etc; but, the 
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formation of the International Society for Extracellular Vesicles (ISEV) in 2011 was followed by 
detailed guidelines for the naming of EVs in MISEV 2014 which also gave guidance on 
separation, isolation, characterisation, and functional studies, and MISEV 2014 was subsequently 
updated in 2018. 
In this century, there has a been an explosion in interest in what are now called extracellular 
vesicles, with the primary difference between EVs and exosomes being that of size. EVs are 
heterogenous in size and range from 50-1000nm in diameter, while exosomes are more 
homogenous in size and range from 50-100nm or 30-120nm in diameter (depending on different 
usages by researchers, and also on the mechanisms by which the exosomes were produced). 
EVs are considered to be a mode of intercellular communication due to their ability to transfer 
cytosolic proteins, lipids, and ribonucleic acid (RNA) between cells and their membranes (Raposo 
and Stoorvogel, 2013). Gould and Raposo (2013) state that there are three sub-groups that form 
EVs: (a) apoptotic bodies (ABs), 800-5,000nm in diameter, (b) cellular microparticles 
/microvesicles/ectosomes (MVs), 50-1,000nm in diameter, and (c) exosomes, 30-120nm in 
diameter  –  although this suggestion has since been superseded by the directives in  MISEV 2014 
and 2018.  
Théry et al., (2002) said that apoptotic bodies are secreted when plasma membrane blebbing 
happens during apoptosis, and that microvesicles (MVs) include vesicles of various sizes that 
pinch directly off the plasma membrane, and that extracellular vesicles are small membrane 
vesicles of endocytic origin that are secreted by most cells. However, for the purposes of clarity, 
it might be useful to make a distinction between  
a) EVs as being nano-sized biovesicles released into surrounding body fluids upon fusion of 
multivesicular bodies and the plasma membrane 
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b) ectosomes/microvesicles that arise from the outward budding and then the fission of the 
plasma membrane where the phospholipid distribution of the bi-layer is governed by the 
amino-phospholipid translocases ‘flippase’ and ‘floppase’ (Muralidharan-Chari, et al., 
2009) 
c) Retro-Virus like Particles that are different fromEVs and microvesicles, in that whilst RLPs 
bud directly from the plasma membrane, the formation of RLPs involves the interaction 
with retroviral proteins such as Gag, Group Antigen Polyprotein (also known as p24) that 
forms the inner layer of the nucleocapsid, and 
d) apoptosome vesicles that are created in the process of apoptosis (Elsmore, 2007).    
 
Goldstein (1961) proposed that ‘tissue crosstalk’ is a mechanism for the physical effects of 
exercise, and since then many studies have studied the effect of physical activity protocols on 
circulating EVs, and the concept of tissue crosstalk during exercise has focused upon uncovering 
novel proteins or peptides, classically secreted, that act in ligand-receptor-binding complexes 
(Whitham & Febraio, 2016). EVs have been shown to be secreted by many different organs and 
tissues in the body, ranging from the brain (Lancaster et al., 2004) to ‘skeletal muscle’ (Moon et 
al., 2016), and it has been suggested that the levels of platelet-derived pro-coagulant proteins and 
monocyte-derived proteins increase when participants perform strength resistance exercises 
(Chaar et al., 2011; Chen et al., 2013; Maruyama et al., 2012). The concentrations of endothelial-
derived MVs do not normally alter (Sossdorf et al., 2011; Wahl et al., 2014), or else they increase 
after endurance exercise of moderate intensity (Sossdorf et al., 2011), and Whitham et al. ( 2018) 
say that proteins can change biological function in recipient cells are secreted in EVs during 
incremental exercise, independently of classic protein secretion. The emphasis in italics is mine 
because protein production accompanies a huge number of bodily functions, and in any case 
identifying certain proteins in the midst of the vast proteomic complexity of plasma is not trivial 
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(Whitham et al., 2018)  –  especially when 50% of protein presence by mass is accounted for by 
albumin alone. 
However, a limited number of studies have assessed the effect of physical activity on smaller EVs 
in the circulatory blood system. In their study, Frühbeis et al. (2015) analysed small (≤200nm) 
EVs detected in plasma during and after performing acute exercise. They found that the 
concentration levels of small EVs increased after cycling exercises and reduced during the early 
recovery phase. However, the reduction might be due to the difference in the dynamics of small 
EVs between these exercise protocols. 
 
1.3.1 Extracellular vesicles 
In normal cell biology, there is constant transport of materials across cellular membranes. This 
transport is thought to be due to an evolutionarily conserved mechanism and involves active and 
passive modes of transport along with trafficking through vesicles, including extracellular 
vesicles, produced by the cell (Azmi et al., 2013). extracellular vesicles are small vesicles (30-
120nm) released by a variety of cell types into the extracellular environment and contain nucleic 
acid and protein, and act as carriers of this cargo between diverse locations in the body (Vlassov 




Figure 5:Illustration of an extracellular vesicle cross-section from Kourembanas (2014). 
 
Extracellular vesicles are nano-vesicles that play a role in the process of intercellular 
communications for transporting proteins and RNAs. Recent studies have shown that they play a 
role in many physiological and pathological processes in the immune system, cell differentiation, 
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and in infection (Zhang et al., 2016). This has encouraged the attempt to use extracellular vesicles 
clinically as a new type of anti-cancer therapy in humans (Chaput and Théry, 2011). 
It has been proposed that many types of extracellular vesicles, either secreted into culture media 
by cells or by different tissues into allied bodily fluids, play a role in communication between 
cells, resulting in either favouring or blocking physiological processes (Lakkaraju and Rodriguez-
Boulan, 2008, Schorey and Bhatnagar 2008, van Niel et al., 2006). Extracellular vesicles have 
been detected in several biological fluids such as plasma, saliva, nasal lavage, placenta, and in 
breast milk (Lässer et al., 2012). The molecular content of extracellular vesicles acts as the 
fingerprint of the releasing cell type and of its status (Properzi et al., 2013), and extracellular 
vesicles levels in plasma are clinically interesting in many applications e.g. the plasma levels in 
some cancer patients could be a potential tool for cancer screening (Logozzi et al., 2009). In 
addition to immune cells, cancer cells secrete immunologically active extracellular vesicles that 
influence both the physiological and pathological processes of the disease (Greening et al., 2015). 
Extracellular vesicles have been detected in blood as an immediate response to exercise by the 
immune system (Li et al., 2006), and Witham et al., (2018) highlight a correlation between an 
increase in several classes of proteins associated with small vesicles and extracellular vesicles and 
robust exercise. Frühbeis et al. (2015) also show that physical activity is associated with the 
release of nano-sized EVs into circulation. Comparing the secretion of inflammatory cytokines 
alongside extracellular vesicles secretions by the immune system, before and after exercise in 
healthy participants, is important in order to identify early markers for reduced immune function. 
Extracellular vesicles have been involved in the pathogenesis of some diseases such as 
neurodegenerative disease and cardiovascular disease (Stoorvogel 2012). It has been shown that 
extracellular vesicles are involved in the accumulation of β-amyloid protein which is associated 
with Alzheimer’s disease (Ohno et al., 2013), and there might be variation between subjects over 
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the course of one day and across several days. Circadian variations are often detected in human 
immune biomarkers, and these have been studied. For example, Ündar et al. (1999) reported a 
significant circadian variation in different blood biomarkers (IL-6), coagulation inhibitor proteins, 
and anti-thrombin factors in healthy men (Ündar et al., 1999). However, the circadian rhythm of 
extracellular vesicles in healthy individuals remains unknown. 
 
1.3.2 Extracellular vesicles in disease 
The production of extracellular vesicles by cancer cells has a critical role in intercellular 
communication, enhancing signalling to neighbouring tumour cells as well as to distant sites 
through blood circulation or biological fluid transportation. One of the areas of research with 
regard to EVs has been the role of EVs in tumour progression and metastasis including fibroblasts, 
endothelial cells, and immune cells, and Khanna et al. (2021) say that evidence of EV presence in 
biological fluids has led to considerable efforts focused on identifying their cargo and determining 
their utility as a non-invasive diagnostic platform for cancer  –  but the role of EVs in many other 
fields such as neurodegenerative disease and cardiovascular disease (Stoorvogel 2012), 
Alzheimer’s disease (Ohno et al., 2013), ocular diseases (Zhang et al. (2020), prostate problems 
(Khanna et al., 2021), thrombosis (Zarà et al., 2019) is also being researched. However, although 
malignant tumours occur at all ages, cancer disproportionately strikes people at the age of 65 years 
or older (Yancik, 2005), and with an ageing population, cancer is going to become an increasing 
cause of mortality, and the role of EVs in identifying cancerous growths will become increasingly 
important (Kobayashi et al., 2015). 
 
In addition to their function in the normal development and physiology of the nervous system, 
extracellular vesicles also play a role in the development of many diseases. According to Ghidoni 
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et al. (2007), extracellular vesicles have been called the Trojan horses of Neurodegeneration due 
to their involvement in transporting toxic substances from unhealthy neurons to neighbouring 
cells.  
As key players in communication between cells, extracellular vesicles enhance tumour 
progression and metastasis by mediating the communication between tumour and stromal cells in 
the human body. However, extracellular vesicles in tumours as well as in normal cells also seem 
to have systemic characteristics (Pucci et al., 2016; Thomou et al., 2017).  
EVs were identified at least 30 years ago (Raposo and Stoorvogel, 2013) and, according to Valadi 
et al. (2007), extracellular vesicles consist of both mRNA and microRNA, that can be delivered 
by intracellular communication. Extracellular vesicles contain specific RNA transcripts that have 
great potential as disease biomarkers (Huang et al., 2013). Emerging evidence reports that 
extracellular vesicles can arbitrate between different biological functions such as cell 
proliferation, angiogenesis, immune response, and antigen presentation by the transfer of proteins, 
mRNAs and non-coding RNAs to neighbouring or distant cells (Pegtel et al., 2011, Huang et al., 
2013). However, the packaging of RNAs into extracellular vesicles is selective as the RNA 
profiles in EVs do not completely reflect the RNA profiles in the parent cells (Valadi et al., 2007, 
Skog et al., 2008). 
It has been hypothesised that since extracellular vesicles carry a particular cellular content, they 
can be exploited as a potential biomedical tool to detect changes in the content of cells, such as in 
the initiation and progression of cancer or tumorous growths (Kobayashi et al., 2015). The miRNA 
content of the extracellular vesicles corresponds only to particular cell types, and EVs are 
attributed with the characteristic of changing the phenotype of the progenitor cells by effectively 
transferring pro-oncogenic molecules in order to initiate the growth of cancers in these cells and 
hence give rise to a metastatic environment in the neighbouring cells (Kobayashi et al., 2015). It 
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has been suggested that an increased level of extracellular vesicles can be detected in urine, serum, 
and in malignant effusions from cancer patients (Ohno et al., 2013). Kharaziha et al. (2012) 
reported that cancer cells secrete higher amounts of extracellular vesicles than normal cells. 
Furthermore, Taylor and Gercel-Taylor (2008) found that cancer patients have excessive amounts 
of blood circulating EVs compared to healthy individuals.  
The prevalence of EVs is therefore important, and this can be used as a marker in many diseases 
including cardiac diseases and cancer. Research studies have reported that EVs in healthy 
individuals are not the same as the extracellular vesicles in diseased individuals (Taylor and 
Gercel-Taylor 2008, Rabinowits et al., 2009) e.g., as in the plasma of patients with lung 
adenocarcinoma (Rabinowits, Gerçel-Taylor et al., 2009) and prostate cancer (Tavoosidana et al., 
2011). It has also been suggested by Huang et al. (2013) that circulating extracellular vesicles 
could play a vital role as a tool for the non-invasive diagnosis and prognosis of human diseases.  
It is the case that the numbers of extracellular vesicles proteins such as CD91, CD317 and EGFR 
have been recognised as potential extracellular vesicles markers of non-small-cell lung carcinoma 
(Jakobsen, et al., 2015).  
 
1.3.3 Muscle development and extracellular vesicles 
Contracting skeletal muscles release cytokines and other peptides acting in a paracrine or 
endocrine manner  –  the so-called myokines (Pedersen, 2009). The term myokine (cytokines 
synthesised and released by myocytes during muscular contractions) was first introduced in 2003 
by the Swedish Professor in exercise physiology, Bengt Saltin. Since myostatin was first 
introduced as a myokine in 1997, secretome-based analysis (analysis of all the secreted proteins 
of a cell, tissue or organism) of human myocyte culture medium has so far revealed over 600 
myokines. These include myostatin, apelin, β-aminoisobutyric Acid (BAIBA), IL-15, IL-6, irisin, 
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SDF-1, decorin, SPARC, and VEGF-A expression, and Whitham et al. (2018) say that given the 
correlation between exercise and the production of EVs, that this might be a mechanism by which 
skeletal muscle can release myokines independent of the classic secretory pathway, but most of 
these mechanisms are currently still not sufficiently understood. 
 
Human apelin was identified and isolated in 1998 as an endogenous ligand of the G-protein-
coupled receptor AP (Tatemoto et al., 1998), while BAIBA was first discovered in human urine 
in 1951, and is a no-protein myokine with a small molecular weight (Crumpler er al., 1951). 
Interleukin 6 (IL-6) was identified in 2000 and it is currently the most studied myokine that there 
is (Steensberg et al., 2000).  
 
With discoveries of myokines (~5–20 kDa in size) continuing to be made, it has been hypothesised 
that muscle cells can act as an endocrine organ (Pedersen, 2009). Besides the release of 
microRNAs, contracting muscle cells have been observed to release EVs containing humoral 
factors, also known as myokines, and these have profound effects on the biochemistry of muscle 
cells (Chan et al., 2004, Febbraio et al., 2004, Izumiya et al., 2008, Ouchi et al., 2008). The 
humoral factors, which are similar to hormones, can have an effect on the metabolism in many 
target tissues and organs (Pedersen and Febbraio, 2008). As they are released in response to 
exercise or intense muscle activity, they may play a plausible role in the adaptation of organs to 
such physical activity, and to contribute to maintaining homeostasis (Guescini et al., 2010). It has 
also been proposed that muscle cells release cytokines such as IL-8 and IL-15, and these are 
important in adapting peripheral organs to physical activity, and to regulate the process of 




Some of the specific miRNAs are miR-1, miR-133a/b, miR-206 and miR-208b, each of which has 
been shown to have a potential role in skeletal muscle development (Chen et al., 2006, Kim et al., 
2006, van Rooij et al., 2009). From these, some miRNAs are released following exercise, and this 
regulates the adaptation of the muscle (Safdar et al., 2009, Aoi et al., 2010, Nielsen et al., 2010). 
Other miRNAs are involved in the uptake of amino acids from dietary intake (Drummond et al., 
2009). These miRNAs are present in different fluids in the body and circulate through them to 
reach their target cells, and hence they are known as circulating miRNAs (c-miRNA). For 
instance, continuous training in intense cycling or rowing for 90 days elevates levels of several 
miRNAs including miR-21, miR-146, miR-221 and miR-222 levels (Makarova et al., 2014). 
Choi et al., 2005 concluded that the release of EVs from the mouse myoblast C2C12 cells in 
culture was accompanied by release of other factors, and this study has focused on the presence 
of mtDNA and several specific proteins in the content of C2C12 cells. The abundance of histone 
proteins in these vesicles is further confirmed by the occurrence of mtDNA. Guescini et al. (2010) 
also identified the presence of several heat shock proteins in the microvesicles released by cells, 
and these included HSP 25, 70, 75 and 90. 
Mylona et al. (2006) performed proteomic analysis of C2C12 secreted EVs and hypothesised 
about their possible role in inter-cell communication. Figure 6 is adopted from Le Grand and 
Rudnicki (20074) who mentioned that quiescent skeletal muscle satellite cells could be activated 
by a stimulus originating from their associated fibre or from the micro-environment. They added 
that their proliferating progeny, the skeletal myoblasts, express the paired-box transcriptions 




Figure 6: Activation, Differentiation and Fusion of Satellite Cells 
 
The study also presented evidence that myotube-secreted EVs reduce myoblast proliferation and 
induce differentiation or promote the process of myogenesis. These EVs vesicles downregulate 
cyclin D1, a cell cycle control protein, and upregulate myogenin, shown to increase 
differentiation. It was found that the EVs secreted by C2C12 cells had specific cell-adhesion 
molecules on their surfaces, and these play a part in the recognition of one myoblast by another, 
allowing myoblasts to fuse with each other (Mylona et al., 2006.). The study thus showed that the 
contents of EVs produced by muscle cells can coordinate myoblasts during differentiation and can 
also act as a medium of communication between myoblasts and myotubes (Forterre et al., 2014). 
In addition, EV-like vesicles released by muscle cells contain proteins of the Guanine family 
involved in many different cellular processes, including myogenesis (Guescini et al., 2010). 
Furthermore, skeletal muscles undergo various molecular and structural changes during the 
process of exercise. These anatomical and morphological changes indicate the high plasticity of 
the skeletal muscles in response to the large amount of stress and load being placed on them 
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(Narici and Maganaris, 2006). This plasticity can be described as a feedback mechanism of the 
body in order to be prepared for the adequate development of its tissues to bear the load and 
strengthen the associated cells and organs to become resilient and hence not to get damaged due 
to high-load or exhaustive exercise activities (Hoppeler, 2016). 
 
1.4 study aims and objectives 
In response to the information that has been revealed by this Literature Review, the aims of this 
study are to measure the content of plasma EVs concentration levels in resting healthy male 
individuals and then to use this information to investigate the systemic concentration levels of 
EVs and inflammatory cytokines in response to high- and low-level eccentric exercise in healthy 
individuals.  
The key objectives of this study are  
1) To measure the content of EVs concentration in human male plasma. 
2) To examine the inflammatory response of the human body to high- and low-level eccentric 
exercise by secretion of inflammatory cytokines and EVs into the circulatory blood 
system. 
3) To measure the subjective response (muscle soreness) and metabolic response (lactate 
measures) to high- and low-level eccentric exercise. 
4) To clarify the potential role of EVs in C2C12 (a mouse myogenic cell line) as a model for 
myogenesis. 
In this study therefore, experimental designs were used to test the following hypotheses. 
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Hypothesis One: That the concentration levels of plasma EVs is stable, and that there is little day-
to-day variability in the concentration levels of plasma EVs over different days of blood sampling. 
This hypothesis will be tested in Chapter Three.  
Hypothesis Two: That there is a change in the concentration levels of plasma EVs and cytokines 
such as IL-6, IL-10 and TNF-α after low and high physical activity, and after eccentric exercise. 
This hypothesis will be tested in Chapter Four.  
Hypothesis Three: That there is a change in the differentiation of C2C12 cells when treated with 






















2.1 The Participants in this study  
2.1.1 Criteria for inclusion in the study 
The study conformed to the latest revision of the Declaration of Helsinki, and all the procedures 
and potential risks associated with the study were fully explained to each participant. All the 
participants reported to the Human Performance Laboratory of Oxford Brookes University and 
completed screening questionnaires to determine their eligibility for participation in this study. 
Participants were eligible for inclusion in the study if they were healthy, male and between 20 and 
40 years of age. Females were excluded because they have hormonal changes that may affect 
inflammation response and EVs concentration levels. In addition to this, women have greater 
adipose tissue than men, and this could be a confounding factor in the relationship between 
physical activity and inflammation.  
Exclusion criteria included the presence of a chronic inflammatory condition (for example, 
diabetes mellitus, or a cardiovascular disease), or the recent consumption of anti-inflammatory 
medications (such as Ibuprofen) by a potential participant. Since the scope of the study was to 
investigate the variation found in the concentration levels of EVs in healthy individuals, the 
indication of any inflammatory condition would therefore suggest a natural increase in the 
concentration levels of EVs and of the proteins that are associated with an anti-inflammatory 
response. Subjects were therefore excluded if they had any pathology known to influence an 
immune response (e.g. auto-immune diseases, anaemia, heart diseases, orthopaedic limitations or 
a renal failure disorder), and also if they had a neurological/ neuromuscular disorder. Subjects 
who had experienced cold or flu symptoms in the previous 24 hours were also excluded from the 
study. 
Because of the natural increase in the level of EVs in cases of inflammatory response, the subjects, 
who were all non-smokers, were excluded from the study if they had had any cold or flu symptoms 
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in the previous 24 hours. Subjects arrived at the laboratory after abstaining from caffeine (for 24 
hours), alcohol (for 48 hours), food (for 8 hours) and exhaustive exercise (for 48 hours). They 
were allowed to consume only water.  All experimental sessions were performed at a time of day 
that was kept constant for each subject, and the purpose, procedures and risks of each study were 
fully explained to each participant. A physical activity readiness questionnaire was completed to 
determine the suitability to participate in physical exercise, and a pre-screening health 
questionnaire was used to check the participants’ medical history to determine (based on the 
answers to specific health-history questions) the safety or possible risk of exercise for each 
participant. Subjects with mental health problems were excluded from the study by asking them 
the question: Have you been treated for any mental health problem before? (cf. Appendix B). 
Subjects were then provided with a written informed consent form (cf. Appendix E) which they 
were required to sign in order to become a participant in the study. 
 
2.1.2 Muscle soreness in the participants 
The visual analogue scale uses verbal mainstays corresponding to numerical values which 
determine the relationship between physical intensity and perception of exertion (Borg, 1982). 
Subjects were asked to self-assess their muscle soreness using a visual analogue scale rating from 
1 to 10, with ‘1’ denoting ‘no pain’ and ‘10’ denoting ‘the worst pain ever’. To capture the 
inflammatory response to exercise, muscle soreness was assessed immediately after the exercise, 






2.1.3 Rate of perceived exertion (RPE) scale 
In order to measure perceptual responses to exercise level and to provide a valuable and reliable 
indicator of exercise tolerance, RPE was used as the subjective measure in this study. RPE is 
monitored during exercise tests, and it has been applied to assess and to understand performance 
(Starbuck and Eston, 2012). It is characterised by subjects’ self-reports of their perceptual 
responses (Merikle, 1992). Responses to exercise level represent the complex interaction of 
various feedback signals from the heart, lungs, muscles, joints and skin in response to stress, effort 
and discomfort caused in the body during exercise (Williamson et al., 2006). It was shown by 
Noble and Robertson (1996), that there is strong evidence that perception of exertion increases 
with increases in workload, force, oxygen consumption, blood lactate, and heart rate (HR) across 
different exercise conditions and modalities. Initially, the RPE scale was developed as a 15-point 
scale from 6-20, and this reflects the range of HR in young healthy subjects from 60 heart beats 
per minute at rest, to 200 beats per minute during maximal exercise on a cycle ergometer. This 
ratio scaling tool showed that the perception of exertion increased with the physical workload. It 
was later revised to the CR-10 scale, which is simpler to use and has shown reasonable validity, 
sensitivity and content (Borg, 1990; Neely et al., 1992) because this is more applicable to 
physiological responses and physical functions (Borg 1990). The CR-10 scale is suitable for use 
alongside various physiological variables and it allows for inter-individual and inter-model 
comparisons. In this study, RPE was used during the eccentric exercise tests, and the CR10 scale 
was used as it is relatively simple to understand and it is suitable for recording measures related 
to the sensation of breathing and to the sensation relating to muscles in the legs (Borg, 1990; Neely 







2.2 Methods used in the examination of EVs concentration levels in the blood samples  
2.2.1 The preparation of EVs 
For each investigation, three blood samples (of 4 ml each) were drawn consecutively from the 
antecubital vein and placed in EDTA vacutainers (Becton Dickinson; San José, California). The 
blood samples were then centrifuged at 1000g for 10 min at 4ºC to separate off unwanted white 
and red blood cells/platelets/and other ‘debris’ that contaminated the EVs. The plasma was then 
separated and divided into 500µl aliquots. The freshly prepared samples (designated as Samples 
A) were then ready for examination, while Samples B were stored at -80ºC ready for thawing and 
subsequent examination. The EVs were then processed as outlined below.  
 
2.2.2 Preparation of samples A (the ‘fresh’ EVs) and Samples B (the frozen and then later 
to be thawed EVs). 
Sample A EVs were isolated by differential ultracentrifugation, and by the basic EVs isolation 
protocols described by Théry et al. (2006). Plasma samples were diluted with an equal amount of 
phosphate-buffered saline (PBS) solution and gently agitated until a homogenous mixture was 
achieved. The mixture was then transferred to 50ml tubes, and centrifuged at 2,000g for 30 min 
and 4°C, followed by 12,000g for 45 min. The suspension was filtered through a 1% bovine serum 
albumin blocked 0.22µm filter, collected in a fresh ultracentrifuge tube, and centrifuged at 
110,000g for 2 hours and 4°C in a Beckman LE-80K centrifuge swing out rotor (Beckman Coulter 
Optima, SW 32 Ti). The resulting pellets were then harvested and washed in PBS by placing them 
in a 14 ml tube with PBS, and then centrifuged for 70 minutes at 110,000g and 4°C.  
The Sample B EVs were prepared in the same way once they had been thawed. 
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2.2.3 The isolation of EVs 
The most used method of EVs isolation depends on a series of successive centrifugations (Lässer 
et al., 2012). Lobb et al. (2015) found that an ultrafiltration method based on centrifugation is 
better and less time-consuming than pressure-driven devices for the concentration of EVs samples. 
The requirement for methods with high specificity using a minimal amount of body fluid led to 
the development of other techniques based on ultrafiltration, immunoaffinity, liquid 
chromatography and polymeric precipitation (Yamashita et al., 2016). Results from these 
alternative techniques were variable, and in the immunoaffinity-based method, the production of 
high purity EVs was expensive. Various trials have used total protein content based on Micro 
Bicinchoninic Acid (BCA) Protein Assay as a technique to quantify and normalise EVs 
preparations before conducting downstream analysis. However, the use of total protein content 
may lead to aggregation with different EVs, and lead to the rupture in vesicle membranes leading 
to false results and study bias.   
Trials aimed at comparing purity and integrity of EVs using different isolation techniques are thus 
still needed. In 2013, Kalra et al. compared alternative methods for EVs isolation from human 
blood and concluded that the density gradient method was better than ultracentrifugation. Kalra et 
al. (2013) evaluated the stability of EVs at different temperatures and found that although all 
samples were stable after three months, there was an advantage in keeping EVs at −80 °C.  
Among these techniques, differential ultracentrifugation is the standard protocol and the most used 
technique for EVs isolation (Théry et al., 2006). Alternatively, EVs can be isolated using either 
sucrose density ‘cushions’ where there is a uniform concentration in the test-tube, or ‘gradients’ 
where there is varying concentration. Because the EVs have a relatively low-density, they float, 
and thus they can easily be retrieved from the supernatant (Cantin et al., 2008, Lamparski et al., 
2002). Ultracentrifugation by itself produces protein contamination, and one of the advantages of 
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using sucrose density gradients is that this method reduces the contamination from large protein 
aggregates that co-sediment with EVs during ultracentrifugation (Tauro et al., 2012). If 
ultracentrifugation is combined with sucrose gradients it can result in a higher concentration of 
EVs (Théry et al., 2006), but the yield would be too low and unreliable for the purpose of this 
study. 
 
Figure 7: Successive centrifugation at 4○C (adapted from Li et al., 2017). 
 
 
2.2.4 The use of ExoQuick™ precipitation to isolate the EVs from the plasma 
The production of commercial kits such as ExoQuick® (System Biosciences) EVs precipitation 
for the isolation of EVs has thus increased rapidly in recent years (Andreu et al., 2016), and the 
commercial EVs isolation kit that was used here was ExoQuick™ precipitation. The isolation was 
carried out according to the manufacturer’s instructions and 500 microlitres (μl) of plasma was 
diluted to 5 millilitres (ml) in PBS and mixed with 1 ml of ExoQuick™ solution by inverting the 
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tube several times. The sample was incubated overnight at 4°C and then centrifuged at 1,500g for 
30 minutes and then centrifuged again for five minutes respectively in order to remove the 
supernatant. The supernatant was discarded, and the pellet was re-suspended in 200ml of PBS. 
 
2.2.5 The Characterisation of EVs  
Challenges in EVs characterisation (according to their size/their surface proteins/their ability to 
bind to specific antibodies/etc) still remain to be clarified in EVs research (Théry et al., 2006), 
and there are various technologies such as optical particle tracking/photon correlation 
spectroscopy/cryo-electron microscopy/etc that can be used to investigate EVs characterisation 
(Taylor and Shah, 2015), but there is no single gold standard method that has been agreed on by 
the experts in the field (Raposo and Stoorvogel, 2013). In this study, EVs have been characterised 
by (i) Nanoparticle Tracking Analysis (NTA), (ii) transmission electron microscopy (TEM), and 
(iii) fluorescent staining with confocal microscopy. These have been the most effective methods 
that have been used in differing EVs studies.  
 
2.2.6 Nanoparticle Tracking Analysis (NTA) to ascertain EVs concentration levels and 
vesicle sizes 
NTA employs direct, real-time visualisation and analysis of nanoparticles in liquids and resolves 
most of the problems that accompany the previously described methods (Gardiner et al., 2013) 
(Figure 8). This technique utilises a laser beam that strikes the sample, and the visualisation of 
vesicles takes place by scattering the observed light through a light microscope. The tracking of 
the Brownian movement of individual vesicles is performed through the video taken by the NTA 
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software (Dragovic et al., 2011), and the size of the vesicles and their total concentration is 
calculated by the diffusion coefficient of the particles (Dragovic et al., 2011). 
Sample suspensions containing EVs vesicles were first diluted and then the samples were kept on 
ice. Samples were analysed using a NanoSight® LM10, NS500 instrument (NanoSight®, 
Amesbury, UK). 90 second videos were used to track the Brownian movement of the EVs using 
Version 2.2 of the NanoSight® software to give mean and median vesicle size and oncentration. 
For every sample, this reading was conducted five times, with mixing in between, and then an 
average was taken to remove sample mixing bias. 





Figure 9: Example of NTA measurement of particle size and concentration. 
The main advantage of NTA is that it successfully resolves one of the fundamental problems 
associated with other light scattering methods (i.e. the problem of dynamic light scattering). It 
does this by having the capability to resolve particles of different sizes at the same time whilst 
utilising the same solution (Dragovic et al., 2011). In spite of its accuracy in measuring the size 
and concentration levels of vesicles, the main disadvantage of conventional NTA is that it cannot 
identify the phenotype nor the origin cell of vesicles. 
 
2.2.7 Variability in technical EVs measurement 
To date, a wide range of EVs physiological and pathological function studies have been 
conducted, but there is a need to understand better the variables that affect plasma EVs 
concentration levels and the mechanisms that control the production and mediation of EVs. Due 
to the pathological involvement of EVs, it is important to know the variability in measuring EVs 
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sizes and concentration levels. An understanding of the variability in size and concentration levels 
may help identify the variety of normal and pathological roles that EVs perform in the body. 
Considering the physiological and pathological importance of EVs as potential biomarkers for 
neurodegenerative diseases and multiple cancer types, there exists a need for measures of the 
content of the concentration levels of EVs in plasma, as this should lead to reliable and accurate 
prognosis of disease initiation and development. Batterham and George (2003) state that within 
subject variation, systemic change in the mean, and re-test correlations are the main measures of 
reliability. It is thus important to measure the bias that can occur in the data affecting measurement 
variability. This can occur in pre-analytical (specimen collection, handling and processing), 
analytical (imprecision and bias), and post-analytical (interpreting and reporting data) data sets 
(Picotte et al. 2009). 
Gardiner et al. (2013) used NanoSight® Tracking Analysis (NTA) to examine the analytical 
measurement variation of the EVs concentration measurement processes. This is essentially a 
technique where a beam of laser light is scattered by particles in Brownian motion in suspension 
in the path of the beam, and a video camera captures the movement of these particles according 
to the prevalence of the different sized EVs. To increase the level of accuracy associated with the 
measurements involved, Gardiner et al. (2013) used silica microspheres of known size as 
standards by which to calibrate the measurements taken. The additive features of the technology 
are distributed across five distinct levels. This allows for the determination of a detection threshold 
which refers to the minimum value for the level of an image that can help distinguish a particle 
for further analysis. The technology used can help to determine the maximum distance that the 
software expects a particle to move from one frame of reference to another. This is directly 
proportional to the size of the particle, and larger particles take longer to move across the frames. 
The minimum expected particle size is automatically determined by the software. ‘Blur’ is another 
automatic setting built into the software and it is defined by the degree of smoothing of the images 
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received by the software after removing unrequired noise (and predominantly includes the 
diffraction rings found around the larger particles). However, a biological standard for EVs 
measurement has not been agreed, and the within-subject variations have not been addressed. 
The NanoSight® equipment can be manually adjusted to cater for larger as well as smaller particle 
sizes. For a particle to be included in the size distribution plot, the equipment determines the 
minimum track length that a particle should cover based on its size. This plot is based on the Mean 
Square Displacement profile for all the particles that have been tracked for a minimum number of 
frames – this being determined by the machine automatically or set manually by the researcher. 
Higher values for minimum track length mean that the particles have been tracked for a greater 
length of time and this helps in the accurate sizing of all the particles under scrutiny. However, 
this does not imply that the particles that spend less time in crossing one frame of reference to 
another one is measured less accurately. It could mean that these particles are smaller in size and 
thus take less time to get across the threshold.  
Lastly, background noise or pixel contamination can be easily removed from the extracted data 
sets or images to make the readings as accurate as possible for the size of the particles. In order 
to develop the importance of their molecular physiology in relation to the function that they 
perform, NTA can be successfully employed to determine the size of biological molecules such 
as EVs (Gardiner et al. 2013). 
 
2.2.8 Same day content 
In order to assess same day content, the same eleven individuals (N=11) participated in this study. 
In the visit, the first fasting blood (consisting of three successive blood samples) was drawn by 
venepuncture using a winged infusion device at the baseline of 0 hours. Then 4ml samples of 
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blood were drawn at hour 1, hour 2, hour 3, hour 4, hour 5, hour 6, hour 8, and hour 10. After the 
second hour and the sixth hour, the participants were offered a standard carbohydrate diet (of 
porridge, oat biscuits and brown toast). A carbohydrate diet is a low-fat diet that provides long-
term energy for the participants and could be picked up in the samples. All the blood samples were 
processed as described in Chapter Two. 
 
2.2.9 Content across several days 
In order to examine the content of plasma EVs concentration levels across multiple days, the same 
eleven participants reported to the laboratory five times over five consecutive days. During each 
visit, each participant had 4ml blood samples drawn at the same time of each day. Each participant 
had a specific time of the day assigned to him.  
 
2.2.10 Transmission Electron Microscopy (TEM) examination of EVs samples to 
characterise their morphology 
An aliquot of the EVs vesicle sample was combined in a 1:1 ratio with 4% paraformaldehyde 
reagent grade (PFA) and cooled for 15 minutes on ice. A single drop of each sample was placed 
onto a strip of Parafilm® (produced by VWR™/Avantor). Carbon-formvar coated copper grids, 
200mesh (F077, TAAB) were placed dull-side down onto the EVs/PFA droplet and left at room 
temperature for 45 minutes. The grids were then placed sample-side down onto three 30μl drops 
of 0.22μm filtered ultra-pure water for one minute each. To remove any excess liquid, the sides 
of the grids between each drop were gently touched with a filter paper. The grids were then placed 
sample-side down onto a 30μl drop of 2% uranyl acetate for two minutes. All the grids were 
touched with filter paper and left to dry, sample side up for one hour. After this, the grids were 
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stored in a box for analysis using a Hitachi H7650 Transmission Electron Microscope (TEM) at 
120 kV.  
 
2.2.11 Blood lactate 
Lactate Pro is a portable blood analyser that uses an electrochemical method of measuring enzyme 
reactions on a small electrode by capillary action straight from a fingertip. Only a few drops (5µl) 
of blood are needed, and this is an advantage when multiple samples are required from each 
individual. In this study, blood lactate concentrations ([La-]) were determined from a fingertip 
capillary whole-blood sample using a portable analyser (Lactate Pro, Arkray, Japan). The fingertip 
area was sterilised with an alcohol wipe and then punctured using a lancet. The first drop of blood 
was removed to avoid sample contamination and the second drop was extracted for analysis. 
2.2.12 Quantikine® enzyme linked immunosorbent assay (ELISA) for cytokine 
measurement 
ELISA (R&D, D6050) was used for the quantitative determination of human Interleukin 6 (IL-6, 
IL-10, and TNF-α) in plasma. All reagents and samples were brought to room temperature before 
use. Working standards and reagents were prepared as directed in the (IL-6, or IL-10, or TNF-α) 
instruction catalogues. Microplate strips were removed from the foil pouch. A 100µl of assay 
diluent RD1W was added to each well, then 100µl of standards, sample or control were added to 
differing wells, covered with adhesive strip and incubated for two hours at room temperature. The 
solution was aspirated and washed from each well, and this process was repeated three times for 
a total of four washes. 200µl of (IL-6, or IL-10 or TNF-α) conjugate were then added and covered 
with new adhesive strips and incubated for two hours at room temperature. The aspiration/wash 
was repeated for a total of four washes. Then 200µl of substrate solution was added to each well 
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and incubated for 20 minutes at room temperature in a dark place. A 50µl of stop solution was 
added to each well. The colour in the wells changed from blue to yellow, and then the plate was 
















Chapter Three - The variability/content of 










3.1 Introduction: aims and objectives 
Different diseases affect the secretion of EVs into the blood stream, and the yield of EVs that can 
be isolated from plasma is influenced by many factors including the method of isolation (cf. 
Chapters 1 and 2) and the method of quantification e.g. NTA/DLS/Flow Cytometry/ELISA/etc. 
For example, Fernando (2017), using three different methodologies, found concentrations of  92.5 
× 108 particles/ml ranging up to 240 x 108 particles/ml. However, yield can be an inverse ‘trade-
off’ against purity, and Gudbergsson (2016) added that the inter-study reproducibility of EV 
analysis including yield is very limited because a standard methodology does not exist. . 
The main aim of this part of this study is to explore the variability/content of plasma EVs 
concentration levels in healthy individuals, and there were two specific objectives in this part of 
the study. 
1) To assess the content of plasma EVs concentration levels from the same individuals, from 
(a) multiple samples of blood taken at the same time point, and also from (b) multiple 
samples taken at different times of the day and (c) across different days. 
2) To determine whether there was any statistical difference in the above measure between 
fresh and frozen-and-then-thawed plasma (hereinafter referred to as frozen/thawed 
plasma). 
Although, circadian variations are often detected in human immune biomarkers, the first 
Hypothesis of this study is that the concentration levels of plasma EVs are stable within the 
sample, and that there is little day-to-day variability in the concentration levels of plasma EVs 
over the five days of blood sampling that was conducted in this study.  
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3.2 Statistical analysis 
The data presented in this Chapter, which related to the participants’ characteristics, are presented 
as mean ± standard deviation (SD). Statistical analyses were performed in SPSS for Windows 
version 21 (SPSS Inc., Chicago, IL, USA). The SPSS normality test showed a box-plot that was 
reasonably symmetrical and in which the Q2 and Q3 quartiles were of roughly the same order of 
magnitude, and there were no ‘outliers’. The analysis also showed that (in accordance with the 
SPSS user manual recommendation) both the Skewness and Kurtosis were not more than twice 
the Standard Error of the Mean, and the assumption of Normality was thus not violated (Statistics 
in Psychology, British Psychological Society-Blackwell). In order to detect any differences over 
the course of one day (at time points 0 hours, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 
8 hours and 10 hours), the variables were examined by one-way repeated measures ANOVA, with 
time as the independent variable, and in like manner across multiple days (days 1, 2, 3, 4 and 5).  
 
By time of day (across all nine time points in one day and across the different days) the content 
was examined by means of a two-way mixed effect model interclass correlation coefficient (ICC 
3,1 as defined by SPSS) for absolute agreement (Shrout and Fleiss, 1979). Tests for 
homoscedasticity showed that the variance in the data was homogeneous, and the ICC 95% 
confidence intervals (95% CI) were calculated. An ICC ≥ 0.7 was accepted, with values of 0.60-
0.74 being considered as good, and 0.75-1.00 as excellent (Cicchetti, 1994). The coefficient of 
variation (CV) was determined for each participant using the formula: SD/mean*100 to determine 
measurement variability, and same day CVs were calculated across the time points. Within the 
sample and across the five-day period, CVs were calculated across the five visits and with the 





Twelve males volunteered to participate in this study, but it proved difficult to find a suitable vein 
from which to draw blood from one individual, and he therefore dropped out of the study. The 
sample size in this study was therefore eleven (N = 11). 
Eleven healthy male participants (aged 27.6 ± 4.2 y, height, 177.0 ± 9.4cm, and of body weight, 
80.3 ± 12kg) thus participated in this study which was approved by the Research Ethics Committee 
of Oxford Brookes University (Appendix A - Ethics Approval Number 130712).  
Table 1: Age/Height/Weight/Blood Pressure/and Heart Rate of the eleven participants in this 
study (Mean ± Standard Deviation (SD). 
Characteristics of the 11 subjects in this 
study 
Mean ± SD 
Age (years) 27.6 ± 4.2 
Height (cm) 177.2 ± 9.4 
Weight (kg) 80.3 ± 12 
Blood pressure (mm Hg) 130/73 ± 7.37 
Heart rate (beat/min) 90 ±  30 
*Data is reported as mean ± standard deviation (SD) 
 
3.3.1 Stability of plasma EVs concentration levels 
In order to assess the stability of plasma EVs under different conditions, fresh and frozen/ thawed 
plasma EVs were isolated by differential ultracentrifugation as described in Chapters 1 and 2. 
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They were analysed by NTA and showed a particle size ranging from 30 to 300nm in diameter, 
with an average of 120 ± 70nm. The concentration levels of fresh and frozen/thawed plasma EVs 
were stable (fresh samples 3.68 ± 3.1, E*108/ml, frozen/thawed samples 4.36 ± 2.8, E*108/ml), 
and there was no significant difference between fresh and frozen/thawed plasma EVs 
concentration levels (p=0.072) in all the eleven samples that were analysed by NTA. However, 
given our small sample size, we cannot definitely conclude that there is no significant difference 
between fresh and frozen plasma EVs concentration levels. Future studies would benefit from 
exploring this further with larger sample sizes. Under the electron microscope, EVs appeared as 








Figure 10: Example of extracellular vesicles characterisation isolated from human blood 
plasma. Observed by electron microscopy they appeared as round cup shaped particles ranging 




Figure 11: Plate A: scanning electron micrographs of   plasma EVs extracted from fresh blood 





Figure 12: Plate B: scanning electron micrographs of frozen/thawed plasma EVs of healthy 
individuals shown by electron microscopy. 
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The total plasma EVs concentration was obtained by NTA. Based on particle size, data were 
divided into two categories: vesicles sized 30-100nm termed EVs, and vesicles sized 101-
1000nm termed ‘microvesicles’ (Fig 13, and 14 below). There was no change in the number of 
both extracellular vesicles. There was also no significant change in the extracellular vesicles 
size within sample. 
 
 
3.3.2 Content/variability of plasma EVs concentration levels within sample, within day, and 
between days 
This study was conducted to assess the content of plasma EVs concentration levels in healthy 
individuals over the course of one day and over the course of several days. The EVs concentration 
levels of eleven healthy men were assessed for content over the same sampling period which 
consisted of ten hours in a single day over the course of five consecutive days. Table 2 shows the 
descriptive characteristics of all the eleven subjects who completed the study. No participant had 







Table 2: Average number of three EVs samples which were measured by NTA under two 
different conditions (fresh, and frozen/thawed samples). Error bars represent Standard 
Deviation (SD). 
Number of subjects 11 
Age (years) 27.6 ± 4.2 
Height (cm) 177.2 ± 9.4 
Weight (kg) 80.3 ± 12 
Blood pressure (mm Hg) 130/73 ± 7.37 
Heart rate (beat/min) 90 ±  30 
*Data is reported as mean ± standard deviation (SD) 
 
3.3.3 Content/variability of plasma EVs concentration levels within the same subject at a 
single time point 
To assess the sample variability of blood plasma EVs concentration levels, three different samples 
that had been drawn consecutively from each subject were measured using the NanoSight® 
equipment. The results from a single level (the sample-variation repeated measures ANOVA test 
performed in this study) showed that there was no significant difference between the concentration 
levels of EVs from the three repetitions of blood collected from everyone (P = 0.676). The sample 
plasma EVs concentration level measures showed excellent content (Cicchetti, 1994) within 
sample (ICCs ≥ 0.88) and minimal variability (Coefficient of variation CV= 42) (Table 3). The 
results therefore show consistent results regarding the concentration levels of plasma EVs within 
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consecutive samples taken at the same time point. Toebe et al. (2018) asserted that larger sizes did 
not decrease CV levels but decreases the variability of the estimate of the same, which increases 
the precision in CV estimation. 
 
Table 3: Within sample measures of plasma EVs concentration levels taken on a single day and 









ICC 95% CONFIDENCE 
INTERVALS (CI) 
Coefficient of 
variation (CV) % 
Within Sample 




















CV showed as SD/Mean *100 
3.3.4 Content/variability of plasma EVs concentration levels and size within the same subject 
at multiple time points during the same day 
To assess the same day content of the concentration levels of EVs from each subject, plasma 
vesicles were measured from the samples taken over the 10 hours during the day. The size 
distribution of the EVs was also measured over the course of a day at different time points and 
across five consecutive days in eleven healthy individuals. 
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A single level repeated measures ANOVA test was performed here. The results show that there 
were no significant differences at any time point (P = 0.95). The average EVs concentration level 
values were 4.8 x108/ml for all time points in all the subjects (represented in Figure 13). The same 
day plasma EVs concentration levels showed excellent (Cicchetti, 1994) content (ICCs ≥ 0.75, 
CV = 30). For size distribution, the results show that there was no statistically significant 
difference at any time point of the day (P=0.14). 
 
Figure 13: Plasma EVs concentration levels of nine samples taken hourly over many hours 
within one day.  The average was that of all participant samples (N= 11), each replicate was 
measured five times on NanoSight® equipment (represented as mean ± standard deviation. Time 
was measured per hour.  
 
3.3.5 Content and variability of plasma EVs concentration levels and size over multiple days 
The variability of the plasma EVs measures demonstrates consistent measurements for plasma 
EVs concentration levels (ICCs ≥ 0.84, and CV = 34%). Over five days the average EVs 
concentration value of each sample was 1.8 ×108/ml. There was no significant difference in the 
concentration levels over five days (P = 0.50). One-way analysis of variance (ANOVA) of the 
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EVs data also showed no significant difference across several days (represented by the average 
value for each of the five days) as shown in Figure 14. Moreover, there was no change in the 
average distribution of the EVs concentration levels of all eleven subjects over the five 
consecutive days.  
 
Figure 14: Plasma EVs concentration levels taken from the average of all participant samples 
(N= 11) over five consecutive days (time was measured per day). Each replicate was measured 




This study assessed the content of plasma EVs concentration levels in healthy male individuals 
within the sample, by time of day and across several days. It has been shown that the concentration 
levels of EVs isolated from blood plasma are consistent, and thus can be a good indicator to use 
in the search for vesicular biomarkers. It was also shown that freezing has no effect on the size 
and concentration levels of plasma EVs. Hypothesis One (that the concentration levels of plasma 
EVs are stable within the sample, and that there is little day-to-day variability in the concentration 
 
62  
levels of plasma EVs over the five days of blood sampling that was conducted in this study) was 






Chapter Four - The role of EVs and 
inflammatory cytokines in response to a single 








4.1 Introduction: aims and objectives of this part of the study 
 
The main aim of this part of the study is to look at the natural variation of inflammatory cytokines 
(IL-6, TNF-α, IL-10) alongside EVs secretion during a normal day, and secretion in response to a 
single bout of eccentric exercise and moderate cycling exercise. The objectives of this part of the 
study are to explore the extent of the systemic release of EVs following different types of exercise, 
and to examine the extent of the correlation between EVs and inflammatory cytokines. We 
hypothesize that there is a change in the concentration levels of cytokines and EVs in plasma after 
eccentric and moderate cycling exercise, the protocol of High et al., 1989 was applied into this 
study because we chose an exercise model that was a stressor to evoke the inflammatory response. 
To test this hypothesis, the following investigation was performed.  
 
4.2 Sample size 
The size of the sample chosen was based on data from a review done by Ploeger et al. (2009), 
comparing the measurement of cytokines (TNF-α, IL-6, IFN-γ) between two healthy groups. With 
an effect size of 0.55, the power of this study was set at 80%, and the level of significance was set 
at 5% (p=0.05 in a two tailed analysis). The size of the sample in this study (N=11) was based on 
a study by Aoi et al. (2013) (cf. Chapter One) which looked at changes in muscle RNA in response 
to different exercise protocols. 
 
4.3 Design of this part of the study 
Cytokines and EVs and especially EVs are released into the circulatory blood system during 
exercise, and the effect of different exercise protocols on circulating cytokines and EVs has been 
reported in different studies (Frühbeis et al., 2015). There is an association between exercise and 
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the secretion of cytokines, and it is suggested that EVs play an important role in immune 
modulation (Zhang et al., 2016). However, although it is becoming increasingly evident that a 
physically active lifestyle is associated with the secretion of lower levels of inflammatory markers, 
many studies have examined the anti-inflammatory response only to leisure-time physical activity 
(Friedenreich, 2011; Il'yasova et al., 2005), and have not investigated whether or not different 
modalities and intensities of physical activity may be associated with changes in inflammatory 
marker secretion levels. The level of exercise is a key determinant of the benefit related to 
exercise, and it is thus important to understand the relationship of different types of exercise with 
the secretion of cytokines and EVs into the circulatory blood system.   
This is an experimental crossover randomised trial with control and experimental groups.  The 
study was designed to explore the inflammatory response in healthy individuals in relation to two 
different types of exercise intensities, (i) eccentric exercise, and (ii) moderate cycling exercise. 
The participants were monitored over a period of ten hours (with hourly monitoring). Blood 
samples collected over that time were kept on ice and then spun for plasma. All plasma samples 
were aliquoted and stored at – 80 °C until needed. 
 
4.4 Experimental procedures in this part of the study 
Extracellular vesicles (EVs) are present in all bodily fluids, and physical activity is associated 
with the release of EVs into the blood circulatory system (Frühbeis et al., 2015). However, little 
is known about the effects of different types of exercise level and the secretions of EVs into the 
circulatory blood system, and there is a paucity of published data on the relationship between 
different modalities of exercise level and the secretions of inflammatory cytokines into the 
circulatory blood system. Moreover, although it is becoming increasingly evident that a physically 
active lifestyle is associated with lower concentrations of inflammatory markers, many studies 
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have assessed only leisure-time physical activity (Friedenreich, 2011; Il'yasova et al., 2005), and 
have not investigated whether or not different modalities and intensities of physical activity may 
be associated with changes in inflammatory marker concentrations. This part of this study 
therefore investigates the EVs response to specific modalities of exercise. 
The following procedure was followed with all the participants attending the study on Day One 
and then attending on Day Two and Day Three. 
Day One (REST): the natural variation of EVs concentration levels over the course of a day was 
tested. Participants were asked to first fill in three questionnaires (as shown in the Appendices), 
to determine eligibility. Results showed all respondents were eligible to participate. A 4ml blood 
sample was drawn by venepuncture using a winged infusion device (BD vacutainer, BD 
VS367288) at the baseline (0 hours), and the needle was sealed with hyper-allergic tape. A blood 
sample was collected every hour for the first four hours by drawing blood from the cannula or the 
butterfly needle. Following this, blood samples were collected at eight hours and at ten hours by 
venepuncture (Figure 17). 
Day Two (eccentric exercise): The study followed the standard high-level eccentric step-up 
protocol (High et al. (1989) that is recognised as causing muscle damage (Newham et al., 1983). 
The eccentric exercise protocol began by each participant placing one leg on a 50cm-high step at 
a hip angle of 90°, and then stepping up and down 20 times while holding a weight equal to 25% 
of his total body weight. A two-minute rest was then given between each set of exercises, and the 
participants were asked to complete five sets of 20 steps-and-rest cycles. The duration of the test 
was approximately 15 minutes. A post-exercise 4ml blood sample was collected immediately after 




Day Three (moderate cycling): Subjects were seated on a friction-braked Monark Ergo-medic 
824E cycle ergometer (Monark AG, Sweden) in an upright posture with the handlebars adjusted 
for comfort. Saddle heights were adjusted to accommodate partial flexion of the knee between 
170° and 175°, with 180° denoting a straight leg position. The Participants’ feet were firmly 
supported by toe clips reinforced with straps, and the heel was held away from the pedal crank 
(Mulcare and Jackson, 2004). 
The participants were asked to engage in a low-level eccentric cycling exercise (Mangione et al., 
1999) by performing an incremental cycle ergometer exercise test. Subjects were asked to pedal 
at a cadence of 60 rpm, and every two minutes the workload was increased by 25 watts until it 
reached 50% of their maximum HR (this was calculated prior to the test based on the participants’ 
physiological parameter measurement from the previous study). Every two minutes, physiological 
parameters (HR, RPE and blood pressure using an arm cuff) were monitored during the exercise 
test period of a total of ten minutes of cycling. Resting and post-exercise 4ml blood samples 
were collected by venepuncture before and immediately after the exercise. On day 3, the EVs and 
cytokine analyses were based only the blood samples of the first three hours. This was done based 
on the results of the previous two days, which showed no changes after three hours. Resting and 





Figure 15: Protocol of eccentric (Day 2) and moderate cycling exercise (Day 3). The 
venepuncture needle stayed in for 6 hours. Subsequently blood was collected by venepuncture. 
 
4.5 Plasma preparation in this part of the study 
All plasma collection and preparation protocols, as described in previous Chapters, were adhered 
to and for this part of the study the University Ethics Committee approval number was 120661 
(Appendix A). Participant Information Sheet is in Appendix B. 
 
4.6 Statistical analysis 
Data are presented as mean ± SD in the tables and text and mean ± SD in the figures. All eccebtric 
and moderate cycling exercise and EVs data were analysed, and statistical analyses were 
performed using SPSS v. 21 (SPSS Inc., USA) and tested for Normal distribution by the Shapiro-
Wilk test. Within-exercise measurements were analysed to detect differences between levels of 
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exercise (eccentric and moderate cycling) with two-way (level × time) repeated-measures 
ANOVAs for the cytokines and EVs and paired-samples t-tests at control and exercise. The 




4.7.1 Subject characteristics 
The participants’ age, height, weight and blood pressure is illustrated in Table 4. Data obtained 
from the eleven subjects in the training intervention were analysed. The table below shows 
descriptive statistics (viz. age, height, weight, blood pressure) of the eleven participants.  
 
Table 4: Subject descriptive characteristics based on subject’s average age, height, weight and 
blood pressure values. 
Age in years 27.5 ± 3.9 
Height, cm 179.6 ± 12.6 
Weight, kg 76.6 ± 16.8 
Systolic Blood Pressure (mm Hg) 126 ±4.4 







4.7.2 Delayed onset muscle soreness and lactate measure 
As measured by the RPE, the participants experienced low levels of pain immediately after the 
exercise (rating of 1.7± 2.5), but the participants reported greater pain 24 hours after the exercise 
(rating of 3.3 ± 2.5) p = 0.01, and the peak of the pain that they experienced was 48 hours after 
the exercise day (rating of 5 ± 2.1). Subject variation was evident on day two ranging from almost 
no pain (a rating of 2), through moderate pain (a rating of 5) and then on to severe pain (a rating 
of 9).  
For the lactate measure, the average lactate level after eccentric exercise was 7.68 ± 1.1 millimole 
per litre (mmol/l), and the average lactate concentration after moderate cycling exercise was 0.88 
± 0.4 mmol/l. 
 
Figure 16: Lactate concentration following eccentric and moderate cycling exercise measured 





4.7.3 IL-6 plasma measurements during rest and in response to eccentric exercise. 
There was a significant difference in IL-6 concentration levels between resting and after eccentric 
exercise (P ˂ 0.02). IL-6 values are presented as means ± SD in Table 5. It was found that IL-6 
concentration levels peaked twice during the exercise experiment day. The first peak was observed 
two hours after the exercise, whereas the most substantial increases in plasma IL-6 levels were 
observed 6-8 hours after the exercise. In contrast, IL-6 concentration levels were undetectable on 
the rest day between hours one to four, with a gradual increase from hour five and a peak at hour 
six on the rest day.  
Table 5: Age/Height/Weight/Blood Pressure/and Heart Rate of the eleven participants in this 
study (Mean ± Standard Deviation (SD). 
Characteristics of the 11 subjects in this 
study 
Mean ± SD 
Age (years) 27.6 ± 4.2 
Height (cm) 177.2 ± 9.4 
Weight (kg) 80.3 ± 12 
Blood pressure (mm Hg) 130/73 ± 7.37 
Heart rate (beat/min) 90 ±  30 
Rate of Perceived Exertion 
(Immediately after the exercise) 
 
1.7 ± 2.5 
Rate of Perceived Exertion 
(24 hours after the exercise) 
 
3.3 ± 2.5 
Rate of Perceived Exertion 
(48 hours after the exercise) 
 









4.7.4 TNF-α concentration levels in response to the exercise modality 
From Figure 17 there was no significant difference in TNF-α average concentration levels between 
rest and eccentric exercise (P= 0.391). The effect of the differing time points on rest and exercise 
did not show any significant difference between subjects (P= 0.739).  
 







Figure 18: EVs average concentration levels at rest and after eccentric exercise. 
 
 
4.7.5 EVs analysis (EVs concentration level measurements between rest and eccentric 
exercise) 
In this part of the study, it was found that the average EVs concentration levels fluctuated during 
the rest day. In contrast, there was a reduction in the average two hours’ EVs concentration levels 
in response to the eccentric exercise day. There was a significant difference between the 
measurement of the first three hours’ average of EVs concentration levels at rest and after 




Figure 19: Comparing of average EVs concentration in eccentric and moderate cycling exercise 
during hours one, two, and three 
 
 
For the moderate cycling exercise, the EVs concentration levels are shown for three hours only, 
because no perceived changes were observed thereafter. The average EVs concentration levels 
fluctuated during a normal day (Figure 20), and there was no significant difference between the 
measurement of EVs concentration levels at rest and the moderate cycling exercise measurement 






Figure 20: Average EVs concentration levels at each time point measured in nine healthy 
subjects following moderate cycling exercise. Error bars are presented as SD. 
 
4.7.6 EVs and IL-6, IL-10 and TNF-α concentration levels in response to eccentric exercise 
There were no significant differences in the eccentric exercise EVs concentration levels and 
cytokine concentrations at any of the time points. Means and standard deviations for eccentric 
EVs and cytokine concentration level measurements are shown in Table 6. There was no 
significant correlation between EVs concentration levels and those of any of the inflammatory 
cytokines. The total plasma EVs concentration was obtained from NTA. Based on particle size, 
data were divided into two categories. Vesicles between 30-100 nm in size are termed as EVs, 
while vesicles between 101-1000 nm in size are termed as microvescicles. There was no change 
in the number of both extracellular vesicles. There was also no significant change in the 




Table 6:  shows values represented as means ± standard deviation of EVs and cytokine 
concentration levels during the first three hours following eccentric exercise. 
Measures Mean of concentration  
 
  







   
 
 
4.7.7 EVs and IL-6, IL-10 and TNF-α concentration levels in response to moderate cycling 
No significant correlation (P > 0.05) was reported between EVs concentration levels and cytokine 
measurements. Means and standard deviations for moderate cycling EVs and cytokine 
concentration levels are shown in Table 7.   
Table 7: Values represented as Mean ± Standard deviation of EVs and cytokine concentration 
levels. 
 
Measures Mean Std. Error 
Exo (E* 108/ml) 332.926 48.548 
IL-6 (pg/ml) 15.594 0.541 
IL-10 (pg/ml) 66.974 5.264 




Figure 21: TNF-α concentration (pg/ml) measured in plasma sample (triplicate) of all 
participants (N= 11) at rest (blue line) and following eccentric exercise (red line). Time was 




Figure 22: Average IL-10 concentrations (pg/ml) were measured for three hours (Time) in rest 




4.7.8 Correlation of EVs concentration levels following eccentric exercise and lactate 
measurements 
The results show that there was an apparent weak correlation between the EVs concentration 
levels after two hours and the concentration of lactate after eccentric exercise. Figure 23 shows 
that when the level of the exercise rose, EVs concentration levels declined. 
 
Figure 23: Correlation of EVs concentration levels measured two hours after eccentric exercise 








It was found that there was a reduction in the average EVs concentration levels after two hours 
following the eccentric exercise. However, a significant difference was observed between the 
average of the EVs concentration levels during the first three hours of rest and the eccentric 
exercise. The hypothesis for this part of study (that there is a change in the concentration levels of 
plasma after moderate physically intense activity, and after eccentric exercise) was therefore 






Chapter Five - C2C12 myoblasts as a model of 





5.1 Introduction: Aim of this part of the study 
Choi et al. (2016) found that in vivo studies have demonstrated that EVs from differentiating 
human skeletal myoblasts increased the number of regenerated myofibers in an injury site but 
decreased the fibrotic area leading to an improvement of skeletal muscle regeneration. However, 
in adult life satellite cells undergo little or no mitosis, but the stress that is caused by eccentric 
exercise can activate the signals for and the mechanisms of muscle cell regeneration of the 
damaged fibres of skeletal muscles (Chargé and Rudnicki, 2004).  
For the purpose of muscle regeneration, myogenic differentiation is triggered in response to 
muscle damage, and the main aim of this part of this study is to establish the extent of the secretion 
of EVs in a C2C12 mouse myogenic cell line as a model for myogenesis. The main aim of this 
part of this study was to clarify the potential role of EVs in C2C12 (a mouse myogenic cell line) 
as a model for myogenesis. In order to do so, the experimental conditions and cell model for the 
differentiation of C2C12 was standardised and the expression of muscle differentiation gene 
markers was analysed by quantitative real time Reverse Transcription-Polymerase Chain 
Reaction. The effect of plasma EVs on C2C12 myoblast differentiation was also explored. 
 
5.2 Methods 
5.2.1 C2C12 cell culture  
C2C12 myoblasts were cultured in Dulbecco's modified Eagle's medium supplemented with 10% 
foetal calf-serum (FCS), and 1% penicillin-streptomycin. The cells were maintained at 37°C in 
5% CO2 and myotube formation (differentiation of C2C12 cells) was initiated upon reaching 
confluence (85-90%) by replacing the growth medium with medium supplemented with 2% heat-




5.2.2 Detachment/dissociation and myotube formation/differentiation of the C2C12 cells 
To achieve detachment, the C2C12 cells were trypsinised at 75-80% confluence, and the cells 
were washed once with 9ml phosphate-buffered saline solution, PBS (Fisher).   
5ml of 0.05% trypsin (Fisher, VX15400054) in PBS was then added to the flask to enable the 
process of cell detachment, and the flask was then put back into the incubator for five minutes. 
After the cells became detached, 5ml of whole cell media was added to the trypsin-cell PBS 
solution and centrifuged at 400g for 5 minutes to pellet the cells. The suspension was taken off 
and the cells were re-suspended in whole media and seeded into flasks at the required dilution. 
The cells were then stored in an incubator at 37°C and 5% CO2. For these experiments the cells 
were seeded at a concentration of 50,000 cells/cm² in 6-well plates.  A 0.5ml of plasma EVs were 
added to the muscle cells (Number of EVs was the amount enriched from 0.5ml of plasma). 
The variable is the number of EVs.  
The C2C12 cells were differentiated for seven days after being seeded at a concentration of 50,000 
cells/cm², and after the cells had reached 85-90% confluence, the growth medium was changed 
and replaced with serum differentiation medium (DMEM, 2% horse serum and 1% Pen/Strep 
antibiotics). PBS was then added to the cells and allowed to differentiate for seven days. In order 
to establish the progress of the differentiation, protein, RNA extraction and slide fixation in 75% 
methanol was carried out every day for seven days, and an immunocyto-fluorescent examination 





5.2.3 Protein and RNA extraction  
For protein extraction, old media was pipetted off and washed with 1ml of cold PBS. 0.5ml of 
radioimmunoprecipitation assay (RIPA) buffer was added and left for 3-5 minutes. The flask was 
placed at an angle for 30 seconds to allow cell lysis, then pipetted into a labelled tube, and stored 
at -20ºC until it was required for analysis. 
For RNA extraction, cells were scraped from the slide, spun down and snap frozen in liquid 
nitrogen and then stored at -80°C until needed for RNA extraction. In order to avoid RNase 
contamination, RNase-free reagents were used in all of the steps of the process. Cell pellets were 
resuspended directly in a lysis buffer and the RNA extracted. An miRCURYTM RNA Isolation 
Kit (Cell and Plant, Exiqon 300110) was used for all RNA extractions. Cell pellets were 
resuspended in 350μl lysis solution and vortex-mixed for 15 seconds. 200μl 95% ethanol was then 
added and the sample vortex-mixed for 10 seconds. A new column was placed in a new collection 
tube and the lysed cell solution was added to the column, and centrifuged at 14,000g for one 
minute. DNase I (Sigma, AMPD1) treatments were performed, according to the manufacturer’s 
instructions, on the RNA whilst it was on the column. The flow-through was retained for protein 
analysis and the column was washed three times with 400μl wash solution for one minute at 
14,000g and the flow-through was discarded. The column containing the washed RNA was 
centrifuged for two minutes at 14,000g to ensure that the column was dry, and it was then placed 
in an RNase-free Eppendorf tube. For elution from the column, 50μl of nuclease free water 
(Ambion, AM9937) was added directly to the column and centrifuged at 200g for two minutes, 
then spun for one minute at 14,000g. The RNA was then measured by NanoDropTM equipment 








5.2.4 Quantitative reverse transcription polymerase chain reaction PCR (qPCR) 
qPCR of RNA samples was used here for validation. Reverse transcriptase from tDNA or mRNA 
can be used to transcribe RNA into primer cDNA, and the cDNA can then be used as the template 
for qPCR.  
Prior to qPCR, cDNA was therefore prepared from cell and extracellular vesicle RNA samples 
that had been quantified using the NanoDrop equipment. For each cellular RNA sample, 2μg of 
RNA was DNase 1 treated (Sigma, AMPD1) according to the manufacturer’s instructions with 2 
units of DNase 1 in a total reaction volume of 10μl. Following DNase 1 treatment, the RNA was 
re-quantified using NanoDrop equipment. For each individual sample, RNA was converted into 
cDNA using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 4368814) 
in a total reaction volume of 20μl, cDNA was also developed for a minus reverse transcription (-
RT) control sample. Samples were stored at -20°C for future use.  
Real-time qPCR was performed using Absolute QPCR SYBR Green ROX Mix (Abgene, 
Courtaboeuf,France) with a Rotor- Gene 6000 system. Results were normalized with the gene 
P21 used as the reference. PCR primer sequences were MYOG CATCCAGTACATTGAGCGCCTA, 
MYOG (myogenin) AS- GAGCAAATGATCTCCTGGGTTG, MYOD ATGATGACCCGTGTTTCGACT, AS- 
CACCGCAGTAGGGAAGTGT, MYF5 GACAGGGCTGTTACATTCAGG, AS- 








5.2.5 Protein quantification (Bio-Rad protein assay) 
Dye reagent was prepared by a dilution of 1 in 4 (one part of dye reagent concentrate with four 
parts of distilled deionised water). The diluted reagent was filtered through 0.22µm filter 
(Millipore, Rev 10/11) to remove contaminants. Five dilutions of protein standard concentrations 
of 0.05-0.5mg/ml were prepared to protein solution. 100µl of each standard and sample solution 
were pipetted into a clean tube and 0.5ml of diluted dye reagent was added and vortex spun. All 
standards and samples were incubated at room temperature for five minutes and then measured. 
 
 








5.2.6 Western blotting/Immunoblotting to identify the muscle differentiation gene markers 
Proteins from C2C12 cells were extracted at different time points and migrated on SDS-PAGE 
gels (30µg). Following electrophoresis, proteins were transferred onto Polyvinylidene Difluoride 
(PVDF) membrane and blocked at room temperature with 5% BSA in tris-buffered saline solution. 
The primary Ab was MF20 was diluted in 1/1000 in 1% BSA.  They were then incubated 
overnight at 4°C on a roller (to eliminate air bubbles between the blot and the blot holder) with 
anti-β-actin (diluted in1/5000) as a loading control. The signal was detected by using a horseradish 
peroxidase (HRP) conjugated secondary antibody (diluted in 1/5000). Finally, membranes were 
scanned on a Bio-Rad ChemiDoc™ MP system. 
 
5.2.7 Fixing the Cover Slips 
Media from each well was taken off with a Pasteur pipette, thus avoiding the touching of the cover 
slip in each well. Each well was washed twice with 2ml of phosphate-buffered saline (PBS) 
solution by adding and removing the PBS with a Pasteur pipette, and then the PBS was gently 
swilled over the well surface before removal. Cover slips were transferred with forceps sterilised 
in ethanol (to kill any mould spores) into the new wells containing methanol to fix them, and then 
each cover slip was gripped by the outside to transfer to the liquid methanol. Cover slides were 
rinsed and left in a refrigerator for 10 min. The forceps were sterilised between the touching of 
each plate and cover slip so as to avoid cross-contamination. After 10 minutes the well was 
removed from the refrigerator and the methanol was taken off the cover slips. Every well was 
washed twice with 2ml cold PBS (using a Pasteur pipette). 3ml of PBS were added to each well 





5.2.8 Immunocytochemistry of C2C12 cells 
Forceps cleaned in 100% ethanol were then used to remove the cover slips from the plate, and the 
cover slips were then placed on an empty dish. 200µl of PBS were added to each cover slip and 
placed on a rocker for five minutes. The PBS was then removed and 200µl of block 1% w/v bovine 
serum albumin (BSA) in PBS was added and incubated on a rocker for one hour. The BSA solution 
was removed, 200µl of mouse monoclonal antibody MF20 (Abcam, ab55152, mouse monoclonal 
to MHC Class II) was added to each cover slip in the ratio of 1:500 in 1% BSA and incubated on 
a rocker for one hour at room temperature. The cover slips were then washed three times for five 
minutes each time in PBS on the rocker. 200µl of goat anti-mouse immunoglobulin-G (IgG) 
antibody (Abcam, ab150113, Goat polyclonal Secondary Antibody to Mouse IgG - H&L) was 
added to each coverslip and incubated on a rocker for 30 minutes in the dark at room temperature. 
The secondary antibody was removed, and 50µl of diluted Hoechst stain (sigma B2261-25MG) 
was added for one minute. The coverslips then underwent three five-minute washes on the rocker. 
The PBS was removed while the cover slips were kept in the dark. 5µl of FluromountTM was then 
added to the centre of each of the labelled slides. The coverslips were removed using tweezers 
and any excess liquid drained off onto tissue, and then the cover slips were placed face-down onto 
the slide. The edges of the cover slips were sealed with nail varnish and left to dry in the dark at 
4ºC until needed. For myoblast fusion measurement, myoblast fusion index (MFI) was calculated. 
The MFI is determined by immunostaining day 0,1,2,3, and 4 differentiated cells (DM) with 
myosin heavy chain (MHC), counting the number of nuclei in each MHC positive cell, and then 
comparing the number of multinucleated cells to the overall number of MHC positive cells. 
Myotubes were considered partially fused if they contained 2–3 nuclei, and fully fused if they 





5.3 Statistical analysis 
The analyses were performed using SPSS 21 software. All the results were expressed in mean ± 
standard deviation (SD). SPSS was used to carry out tests for Normality and Homoscedasticity, 
and Gosset’s parametric ‘student’ t-test was used to compare the means, and a ‘p’ value of 0.05 
was considered significant. A one-way ANOVA was performed for the comparison of one 
variable in different groups. The results were analysed using the ΔΔCt method to quantify the 
relative abundance of mRNA and plotted as a fold change relative to one of the ‘housekeeping’ 
genes. qPCR data was shown by calculating the fold difference. Cycle threshold (Ct) is the number 
of PCR cycles at which the fluorescence signal increases above the threshold value. The data was 
analysed by comparing ∆∆Ct results of C2C12 cells treated with EVs from exercised and rested 
participants respectively. 
Fold Difference = 2ΔCt 
ΔCt = Ct gene of interest – Ct HKG 
∆∆Ct = ∆Ct Day0 cell differentiation - ∆Ct sample x 
P values less than 0.05 were considered statistically significant.  
 
 
5.3.1 Determination of the fusion index 
 
 
Pictures were captured with a Leica camera in five-by-five tiled pictures using Zeiss fluorescence 
microscopy. The images were then counted, and the fusion index was calculated as the percentage 
of myotube cells which contained two or more nuclei versus the total number of nuclei. The 
number of nuclei in myotubes and the total number of nuclei in the cells were counted by using 
(ImageJ 1.44) (64-bit) software. The fusion index was calculated as the percentage of myotube 





5.4.1 Treating differentiated C2C12 cells with PBS 
In order to show that C2C12 differentiation had taken place, images of C2C12 cell differentiation 
were taken by fluorescence microscopy. A significant difference of the fusion index was detected 
between Day 0 vs. Day 1 (P = 0.023), Day 1 vs. Day 2 (P =0.0005), Day 2 vs. Day 3 (P = 0.0009), 
and Day 3 vs. Day 4 (P = 0.044). This significant increase reflects C2C12 myogenesis over the 
course of differentiation.  
 
Figure 25: This is the fusion index following differentiation of C2C12. C2C12 myoblasts were 
seeded at a concentration of 50,000 cells per well and allowed to differentiate for the times 
indicated. Error bars represent SDs. All the values were significant (p<0.05) in comparison to 





5.4.2 The expression of Myogenic regulatory markers during C2C12 cell differentiation 
Over the course of C2C12 differentiation, expression levels of myogenic markers (Myogenin and 
MyoD1) were determined by qPCR at different time points following the induction of C2C12 
differentiation. The MyoD1 level was slightly altered around t= 48h and decreased beyond t= 72 









Figure 26: Relative mRNA quantification concentration by qPCR from the myogenic markers 
Myogenin and MyoD1 compared to PPIA housekeeping gene. This is an average of three repeat 






Figure 27: C2C12 myoblasts induced to differentiate by culture for the indicated times in 
differentiation medium, and subjected to immunofluorescence analysis with anti-MHC Class II 
antibody, and nuclear counter-stained by Hoechst sigma B2261-25MG. Images of C2C12 cells 
differentiation taken by fluorescence microscopy. 
 
 
5.4.3 Treating differentiated C2C12 cells with plasma EVs 
In order to explore the effects of EVs on C2C12 differentiation, the experiments in this  study 
were repeated in which C2C12 cells were seeded at the concentration of 50,000 cells per well. 
After the cells had reached 85-90 % confluence, the growth medium was changed and replaced 
by serum differentiation medium (DMEM, 2% horse serum and 1% PBS). Plasma EVs that had 
previously been extracted from six healthy participants who had undergone two hours of eccentric 




(Figure 28). Protein, RNA extraction and slide fixation in 75% methanol were done every day for 
seven days. 
 
Figure 28: MFI of C2C12 at Day three of differentiation after treated by EVs previously 














Figure 29: shows C2c12 at different days of differentiation after treatment 
In day two of differentiation, C2c12 was treated by EVs previously extracted from resting plasma 
sampling. In day three, C2c12 was treated by EVs previously extracted from eccentric exercise 





5.4.4 Quantification of Myogenin by Western Blot analysis 
There was a problem with loading control in myogenesis ( beta- actin) not getting normalized 






Figure 30: shows figures of myogenin quantification by western blots.  




5.4.5 The expression of Myogenin change in EV-treated C2C12 cells 
The expression level of Myogenin in EV-treated C2C12 cells by plasma samples was determined 
by qPCR. It shows reduced Myogenin in all treated plasma samples at the time point t= 27h, but 





Figure 31: The expression of Myogenin change in EV-treated C2C12 cells 
mRNA from the myogenic markes Myogenin, MyoD and Mrf4. Transcription levels are 
expressed as relative quantities compared to the intiation of differentiation ( t=0h). 
222, 322,522,922 and 1122 refer to  EV’s samples previously extracted from eccentric exercise 








Our study may provide a basis for future research. Our overall results suggest that physical 
exercise induces a release of small extracellular vesicles called EVs into the blood circulatory 
system (Frühbeis et al., 2015), and the effect of exercise protocols on the secretion of circulating 
EVs has been reported by different studies. However, our research had several limitations that 
future studies can address. 
One of limitation of this study is C2C12 a secondary muscle model which does not reflect muscle 
myogensis in human, however C2C12 is more versatile, more ethical and reflect muscle model 
very well. 
In future study, I would prefer to repeat this experiment on exercise mice though primary cell line 
is more expensive and ethical hard to get it. 
Another limitation is EV’s counting as in this study Ev’s were measured by NTA, in which there 
is an argue that NTA is not the gold standard and there is other method such as I Zone tend to be 
more precise though the main issue with it is blocking up and contamination. 
In future study, I would do EV’s measure by counting their number by hand or set up a computer 
programme which can count the number of these vesicles from electron microscopy images. 
Also, this study was conducted only in young males which could not be generalising to reflect the 
whole population. In future study, I would do four groups of young males/young females, old 













6.1 Hypothesis One 
“The concentration levels of plasma EVs are stable, and that there is little day-to-day 
variability in these concentration levels over different days of blood sampling”.  
Chapter Three of this study examined the effect that different conditions have on the stability of 
EVs concentration levels, and it was shown that there is no significant difference between the 
biologic activity of EVs derived from frozen-and-then-thawed plasma and that of EVs derived 
from fresh plasma. The blood plasma was then pooled and prepared for EVs isolation. These 
findings are consistent with Kalra et al.’s (2013) study, which reported that freezing had no effect 
on the size and concentration levels of plasma EVs. Kalra et al. (2013) also assessed the stability 
of EVs in plasma under various storage conditions, and over the course of 90 days from frozen 
and then thawed plasma samples and also from fresh samples obtained from five healthy donors. 
The authors found that, western blotting analysis revealed that EVs are stable for 90 days. They 
also found that the isolated EVs were able to fuse with target cells revealing that they were indeed 
biologically active (Kalra et al., 2013). Kalra et al. (2013) concluded that the density gradient 
centrifugation allows separation of vesicles based on their buoyant densities and isolation of pure 
population of EVs from blood plasma. However, density gradient centrifugation method cannot 
be employed effectively in clinical experiments. Therefore, robust and efficient methods to isolate 
EVs need to be developed. 
A study conducted by Lässer (2012) discussed some methods used for isolating EVs and their 
RNA cargo, however these methods could impact the purity and quality of the isolated RNA. 
Furthermore, this study found that processing of body fluids could be more problematic and 
complex than cell culture media, as the body fluids is viscous and difficult to retrieve. This may 
result in lower EVs yields. Therefore, a well-established method for EVs isolation is needed. 




extracellular vesicle in addition to EVs such as microvesicles and apoptotic bodies which could 
contaminate the EVs fraction. Therefore, validation by different identification and detection 
methods can improve quality of the results. In 2016, Lässer et al. have conducted another study 
that described the importance of having well-established protocols for EVs’ isolation and 
characterization by combination of different methods including electron microscopy, NTA, flow-
cytometry and western blot to get high-quality results. 
 
This study has also examined the content of plasma EVs concentration levels within-and between-
subjects and it was shown that EVs are stable and reliable and that they can be used as a good 
indicator for vesicle biomarkers. This study first examined the within-sample content of three 
different samples drawn from each individual at the same time and found that there was no 
significant difference between the three different repetitions of blood collection at the 5% alpha-
level. Since the results showed good content, this suggests that there were no technical issues that 
needed attention with regard to taking blood samples from the same participant at any one 
particular point in time during a day. This study then examined the same day content of plasma 
EVs concentration levels over different time points (10 hours of monitoring) during a given day 
and found that there was no significant difference at any of the different time points. This suggests 
that, if nothing unusual happens during the day, EVs concentration levels are stable over the 
course of any one day. There were also no significant differences in the measures taken across 
five consecutive days. 
The results demonstrate that plasma EVs concentration levels are stable in healthy subjects. The 
intraclass/intracluster correlation coefficients (ICCs) were ≥ 0.8 for within-sample measures taken 
across five days and for same day, and Cicchetti (1994) regards coefficients between 0.75 and 




The study examined the stability of plasma under different conditions. Plasma EVs concentration 
levels were also analysed with regard to particle size. The data were divided into two categories, 
vesicles 30-100nm in size which are known as ‘exosomes’, and microvescicles where the size 
range is 101-1000nm. There was no change in the concentration levels of both these types of 
extracellular vesicles. There was also no significant change in EVs concentration levels within the 
same subject at multiple time points of the day and over multiple days. 
 
6.1.1 Limitations 
There were several limitations in the study that could have contributed to increased variability in 
the measurement of plasma EVs concentration levels but did not do so. Firstly, there was no 
dietary control nor a dietary record for the participants e.g. it was not known what the subjects 
had eaten the previous day. However, the study attempted to control this, both by asking all the 
participants to fast and also by collecting blood samples at the same time of day over the five 
consecutive days. Secondly, physical stress is related to various immune changes, and this could 
be one of the physiological factors that fluctuates from day to day (Herbert and Cohen, 1993). It 
is therefore suggested that stress could be a possible cause for the variability in EVs concentration 
levels over a period of several days. However, the study attempted to minimise this by asking the 
participants to report to the laboratory at the same time every morning to ensure that the blood 
collection was conducted while the participants were in a rested state. Thirdly, the small sample 
size could have been one of the study’s limitations, but the results showed good to excellent 
content with regard to the ICC coefficients. However, since this study was confined to male 
subjects, further research would need to be conducted among women to confirm the content of 
plasma EVs concentration levels in human blood in general. Additionally, results cannot be 




may still bear clinical significance, highlighting the need for future studies with larger sample 
sizes.  
 
6.2 Hypothesis two 
“There is a change in the concentration levels of plasma EVs and cytokines after low- and 
high-level physical activity and after eccentric exercise”.  
Many research papers have assessed only leisure-time physical activity (Friedenreich, 2011; 
Il'yasova et al., 2005) and have not investigated whether or not different modalities and levels of 
physical activity may be associated with changes in inflammatory marker concentration levels.  
This study found that the incremental cycle ergometer test was well tolerated by the subjects, and 
all the physiological parameters and perceptual markers indicated that the subjects were achieving 
50% of their maximum heartbeat. In this study, no significant difference in EVs and cytokine 
concentration levels were recorded after low level physical activity, and there were no significant 
differences in lactate measures after the exercise. However, EVs concentration levels markedly 
decreased after eccentric exercise compared to the resting state. This study thus found no evidence 
that inflammation and the prevalence of EVs is linked. In contrast, there was a negative correlation 
between EVs concentration levels two hours after eccentric exercise and lactate concentration 
levels. Lactate is an aerobic metabolite, consumed by skeletal muscles and by the heart when 
oxygen levels are sufficient, and it may contribute to acetyl-CoA production (Chatham, 2002). A 
major amount of muscle-derived lactate is transported to the liver to be used in glucose synthesis 
through gluconeogenesis; glucose is then transferred to the blood circulation to the muscles to be 




In response to the eccentric exercise, no significant correlation was reported between the 
prevalence of EVs and any of the inflammatory cytokines IL-6, IL-10, and TNF-α. There was a 
reduction in EVs concentration levels after eccentric exercise but there was an increase in IL-6 
concentration levels, and several mechanisms could be responsible for this difference. One could 
be that eccentric exercise could affect the protein and miRNA content of EVs. Another possible 
reason for a reduction in EVs concentration levels could be that EVs are taken in by contracted 
muscles and are involved in the recovery process which helps to repair the damage caused by 
eccentric exercise. However, the most likely reason for secretion and uptake still remains to be 
determined. Further research is required to measure muscle-enriched microRNA and protein 
changes before and after eccentric exercise. 
In this study IL-6 concentration levels were below the sensitivity of the enzyme linked 
immunosorbent assay (ELISA) in the first few hours of the rest day, but there was a gradual 
elevation in IL-6 concentrations after the fourth hour and a peak at six hours on the same day. 
Furthermore, it was found that IL-6 concentration levels peaked twice during the exercise 
experiment day. The first peak of IL-6 was observed one hour after the eccentric exercise, whereas 
substantial increases in plasma IL-6 levels were observed between six and eight hours after the 
exercise. This variation in IL-6 plasma concentrations could be due to the effect of nutrient intake 
on the immune system which was noted in the study conducted by Gleeson (2004) (cf. Chapter 
One). Nehlsen-Cannarella et al. (1997) state that the consumption of carbohydrates during 
strenuous exercise attenuates the stress hormone increase of cortisol and epinephrine along with 
pro-inflammatory cytokines. This study therefore tried to control food intake by choosing light 
meals containing only carbohydrates. Participants were given food after two and after six hours 
after starting the study, and a gradual elevation in IL-6 concentration levels was found after the 




The concentration of TNF-α did not significantly change between rest and after eccentric exercise. 
This might be due to the fact that muscle damage during eccentric exercise may result in pro-
inflammatory cytokine accumulation (Scott et al., 2013). This conflicts with the evidence that 
TNF-α does not accumulate in, nor is it released by contracting muscles during eccentric exercise 
(Scott et al., 2013). 
 
6.2.1 Limitations 
A sample size of eleven subjects in this study was based on the calculation discussed in Chapter 
Four in Section 4.2. This small sample size may not be sufficiently robust to reflect the 
characteristics of the total population, but it is sufficient to show significant molecular changes in 
human beings. Furthermore, the difference in exercise intensities between subjects might have 
been caused by the difference in fitness between subjects (athletes and non-athletes). This could 
have been measured by VO2 max, but that was not the focus of this study. Each one of the tests 
took place over a period of approximately ten minutes. Additionally, control over the weight load 
was set at about 25% of total body weight. How difficult the activity was to perform and how tired 
the muscles felt was determined by measuring the heart rate and the lactate level.  
 
6.3 Hypothesis Three 
“There is a change in the differentiation of C2C12 cells when treated with plasma EVs”.  
Chapter Five of this study examined the effects of eccentric exercise EVs on C2C12 muscle cells 
as a model of differentiation. The experimental conditions were first standardised for the C2C12 




their involvement in differentiation was analysed. The expression levels of Myogenin and MyoD1 
were slightly increased after the start of differentiation. At around 48 hours, the Myogenin gene 
was up-regulated more than two-fold, while beyond t = 72 hours it was up-regulated ~100-fold. 
For MyoD1, the expression level was up-regulated beyond t = 48 hours, while its expression more 
than halved beyond t = 72 hours. For the myogenic regulatory factor MRF4, transcripts were not 
detected during C2C12 differentiation. The study also looked at the myogenin expression in EV-
treated C2C12 cells by plasma sample, but no significant reduction in myogenin expression level 
was found. This may be because a larger plasma sample was needed because qPCR is a sensitive 
assay that needs more samples. (However, the MIQE guidelines for qPCR analysis recommends 
triplicates). 
The expression of muscle differentiation genes (Myogenin, MyoD1) was consistent with the 
expression pattern described in the literature (Janot et al., 2009, Delgado et al., 2003). In Janot et 
al.’s (2009) study, 95 exhibited altered mRNA expression among the 276 genes expressed when 
C2C12 cells differentiated and 37 displayed more than 4-fold up- or down-regulations. These 
genes were clustered in three main groups. The first cluster had genes with gradually reducing 
quantities of transcripts where transcript levels reached a maximum at 24-48 h of differentiation 
in the second set of genes and then diminished. The thirst set of clustered genes increased 
throughout differentiation. The authors concluded that the myoblast cell membrane and ECM 
could be modified for cell fusion during C2C12 differentiation.  
This study provided evidence that C2C12 as a model of differentiation shows a gradual increase 
in C2C12 myogenesis over 7 days of differentiation, even when treated with the EVs experimental 
carrier PBS. Hoechst staining of the nuclei shows that there are multinucleated myotubes from the 
myoblasts. Cells were imaged and analysed to obtain the fusion index as the percentage of 




of cell differentiation, and the findings of the study are consistent with those of other studies (Janot 
et al., 2009). Once the model had been established, this study then examined the effect of treating 
differentiating C2C12 cells with plasma EVs previously extracted from six healthy participants in 
rest periods and also two hours after the participants had performed eccentric exercise. On the first 
day of the C2C12 differentiation process, eccentric EVs samples were added and allowed to 
differentiate for 7 days. It was found that eccentric exercise EVs resulted in decreased C2C12 
differentiation (formed fewer multinucleated structures) at Day 3 of differentiation than did 
C2C12 treated with rest EVs from the same participant or the PBS control treatment. This 
reduction suggests that stress induced by eccentric exercise has an effect on muscle differentiation, 
and it may be that the reduction of systemic EVs indicates that they have already been re-absorbed 
back into damaged tissue. This could explain the reduction (found in this study) in C2C12 
differentiation when plasma EVs extracted from healthy participants after performing a eccentric 
exercise were added. However, further in-vivo testing is required.    
A study conducted by Fabbri et al. (2012) showed that some miRNAs secreted by tumor cells in 
EVs can bind to TLR8 (and TLR7) and activate these receptors in immune cells, leading to 
activation and secretion of prometastatic inflammatory cytokines. This could explain EV’s 
secretion and stimulation could be induced because of the binding of toll-like receptor to miRNA 
expressed on EVs’ vesicles surface. 
Other studies (Valadi et al. 2007, Kosaka et al. 2010, Mittelbrunn et al. 2011) have shown that 
exercise may increase the uptake of miRNAs from the blood circulatory system into other 
recipient cells, and specifically EVs might be taken into muscle cells (Aoi et al. 2010). 
Another study conducted by Coenen-Stass et al. (2016) demonstrated that the same extracellular 
microRNAs shown to be secreted during myogenic differentiation also increased systemically 




concentration levels were reduced after eccentric exercise, and it is to be expected that this would 
cause delayed onset muscle soreness. The findings of this study were therefore consistent with the 
findings of other studies. However, the exact mechanism of secretion and uptake remains to be 
discovered. Further research is required to understand the impact of exercise induced muscle 
damage on EVs secretion into the circulation systems of human beings. 
Since EVs play a potential role in myogenesis, then this role can be further elaborated by more 


































7.1 Conclusion  
It has been reported that physical exercise has an impact on physiological biomolecules and is 
associated with a number of immediate physiological responses along with long-range 
homeostatic processes (Yáñez-Mó et al., 2015). Furthermore, it has been reported that physical 
exercise induces a release of small extracellular vesicles into the blood circulatory system 
(Frühbeis et al., 2015), and the effect of exercise protocols on the secretion of circulating EVs has 
been reported by different studies (Maruyama et al., 2012, Chen et al., 2013). In addition to the 
interest in EVs as potential biomarkers, their physiological roles have been the main focus of 
recent research into the pathways relating to intracellular and intercellular communications (Nolte 
et al., 2016). 
In recent years a wide range of EVs physiological and pathological function studies have been 
conducted (Zhang et al., 2016, Ailawadi et al., 2015, De Toro et al., 2015). Despite the increasing 
number of studies examining plasma EVs, there is a need to understand better the variables that 
affect EVs concentration levels and the possible variation in between-subjects over a day and 
within a day. 
A study by Gardiner et al. (2013) showed data from several repeat measurements of known 
concentration of EVs. However, a biological standard for EVs measurement has not been agreed 
and the within-subject variations have not been addressed. This study has endeavoured to explore 
the content of plasma EVs concentration levels in healthy individuals. In order to determine 
whether the method of extracting EVs was reproducible, three blood samples were drawn 
consecutively from the same subjects into EDTA vacutainers. The study tried to assess within-
day content by taking multiple blood samples over a period of 10 hours, and plasma EVs content 




times over five consecutive days. The study showed that EVs concentration levels isolated from 
blood plasma are consistent and can be used as a good indicator to search for vesicular biomarkers. 
EVs have been detected in blood as an immediate response of the immune system (Ji et al., 2006). 
It is also known that physical exercise induces cytokine secretion into the circulatory blood system 
that begins 3 hours after exercise and lasts until 12 hours after the exercise (Petersen and Pedersen, 
2005). Although far less is known about the effects of eccentric exercise on EVs secretion in the 
circulation system, the effects of eccentric exercise on the immune system are well documented. 
The pro-inflammatory cytokines, TNF-α and IL-1, are the first two cytokines to appear in the 
cytokine cascade (Petersen and Pedersen, 2005), therefore a comparison of inflammatory cytokine 
secretion alongside EVs secretion as a response before and after physical exercise in healthy 
subjects is important in order to identify early markers for reduced immune function. This study 
therefore looked at the natural variation of inflammatory cytokines (IL-6, TNF-α, IL-10) alongside 
EVs secretion during a normal day and in response to a single bout of either eccentric exercise in 
eleven healthy subjects. The study found no significant correlation between the concentration 
levels of EVs and any of the inflammatory cytokines (IL-6, IL-10, and TNF-α) in response to 
eccentric exercise and moderate exercise.  
However, it was found that eccentric exercise evokes a significant IL-6 response. There is a 
significant difference between the concentration levels of resting IL-6 and eccentric exercise IL-
6, but the study did not find that the concentration of TNF-α altered significantly between rest and 
post eccentric exercise. This result is similar to the findings of Rall et al. (1996) and McFarlin et 
al. (2004) who found that eccentric physical exercise did not reduce the levels of TNF-α. This 
may be due to the fact that muscle damage during eccentric exercise can result in pro-
inflammatory cytokine accumulation (Scott et al., 2013). However, this conflicts with the 




eccentric exercise (Scott et al., 2013). For IL-10 there was no significant difference between rest 
and post-exercise concentrations, and for cytokine measurements/results, the findings of this study 
were consistent with the study by Petersen and Pedersen (2005). 
The findings of this study suggest that there is a reduction in the average EVs concentration levels 
two hours the eccentric exercise day, and a significant difference between the measurement of the 
first three hours’ averages of EVs concentration levels in rest and after eccentric exercise was 
observed. 
This study measured the extent of the subjective response (muscle soreness) and metabolic 
response (lactate measures) to eccentric exercise for all subjects and found a positive correlation 
between intense exercise and EVs concentration levels. The study also made a comparison 
between RPE and EVs and cytokine concentrations and found that there was no significant 
change, but this could be a result of the size of the sample. A potential reason for why no response 
was observed is that our sample was comprised primary of young, healthy adults. 
This study suggests that, in response to exercise, the skeletal muscles induce a rapid release of 
extracellular vesicles with the characteristic size of EVs into the blood circulatory system. The 
findings are consistent with those of Aoi et al. (2013) in which EVs released during physical 
exercise may participate in cell communication during exercise-mediated adaptation processes.  
Another possible mechanism could be that eccentric exercise destroys EVs and leads to the 
degradation of the body’s own miRNA. A further reason for a reduction in EVs concentration 
levels could be that EVs are taken in by contracted muscles and are involved in the recovery 
process from damage caused by eccentric exercise. According to Aoi et al. (2013), regular 
exercise can improve skeletal muscle function along with adaptation effects in all other tissues in 




during exercise. It has been shown that EVs play a potential role in myogenesis and this could be 
further studied by conducting more research on EVs released by muscle cells. In order to study 
the development and differentiation of myocytes, this study was set up to observe C2C12 cells in 
culture, these being commonly used as a model to study skeletal muscle cell differentiation 
(Burattini et al., 2004). 
Chapter Five of this study examined the effects of exercise EVs on C2C12 muscle cells as a model 
of differentiation. The experimental conditions for the C2C12 model of differentiation were first 
standardised, and the study then used qPCR to analyse the expression of myogenic markers 
(Myogenin, MyoD1) that are known for their involvement in myogenic differentiation. The 
findings showed that the expression of myogenic regulatory markers (Myogenin, MyoD1) was 
consistent with the expression pattern described in the literature (Janot et al., 2009, Delgado et al., 
2003). The study also provided evidence that C2C12 as a model of differentiation was 
standardised from immunocytochemistry, and this showed a gradual increase in C2C12 
myogenesis over 7 days of differentiation after treatment with PBS. 
The study then examined the effect of treating differentiating C2C12 cells with plasma EVs that 
were previously extracted from six healthy participants both at rest and two hours after the 
performance of high-level eccentric exercise. On the first day of the C2C12 differentiation 
process, plasma samplings were added and allowed to differentiate for 7 days. It was found that 
eccentric EVs resulted in decreased C2C12 differentiation that expressed less myosin and formed 
fewer multinucleated structures at Day 3 of differentiation than C2C12 treated with rest EVs from 
the same participant or from the PBS control treatment. This reduction suggests that stress induced 
by eccentric exercise may destroy EVs vesicles. According to Aoi et al. (2013), acute exercise 
induces reductions in circulating miRNA, and this could be associated with changes in metabolic 




system. This is particularly relevant for miR-486 which is one of the muscle-enriched miRNAs 
that decreases in circulation in response to acute exercise. The exact mechanism of secretion and 
uptake remains to be elucidated. Further research is required to investigate the exact physiological 
role of EVs in response to exercise level and to identify the effects of different exercise intensities 
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Professor Helen Dawes 
Director of Studies 
Department of Sport and Health Sciences 
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12 March 2013 
 
Dear Professor Dawes 
 
UREC Registration No: 130712 
The influence of strenuous exercise on the inflammatory process in healthy participants 
 
Thank you for submitting the application to the University Research Ethics Committee on behalf of your 
research student Eman Abu-Seer. The Committee reviewed the application at its meeting on the 27 
February 2013, and have agreed approval subject to meeting the following conditions: 
 
1. It is unclear why the SF-36 and PASE questionnaires are repeated on days 1 & 2 of testing.  
Please would you explain the rationale for this? 
 The validated questionnaires on Day 1 are: 
General health status questionnaire (SF-36) 
Physical activity level questionnaire (PASE ), this was adapted and validated for use in young adults and this 
questionnaire is appropriate and valid for Multiple Sclerosis (MS) which i will conduct the same study on them 
after healthy participants. 
Fatigue severity scale questionnaire (FSS). 
 
Day 2 
Fitness test questionnaire (CRF) 
Visual Analogue Scale (VAS), to measure changes in muscle soreness which caused by strenuous exercise. 
Vitality Scale ( Individual Difference Level Version ,State Level Version ), this scale is considered as an aspect 
of eudemonic well-being, as being vital and energetic is part of what it means to be fully functioning and 
psychologically well. (Ryan & Deci, 2001) 
So SF-36 and PASE on Day 1 only and are not repeated on Day2. 
 
 
2. It is proposed that participants would be drawn only from the movement science group (2.2 
and 2.3).  However, reference is later made to the potential for dependent relationships 
between researchers and students (2.5).  Please clarify exactly who would be invited to take 
part, how and the steps that would be taken to avoid any unintentional coercion of peers / 
colleagues.  It is inappropriate to approach individuals directly as it is difficult to decline to be 
involved if invited by word of mouth – so a less direct method should be used.    
   
Participants will be recruited through students or staff contacts and word of mouth.  Individuals who show 
interest will be given a brief explanation of the study, either orally or by email depending on how they make 
initial contact. If potential participants are interested in getting involved, a participant’s information sheet will 
be sent to consider their decision by returning a reply slip wishing to participate in the study after given of at 




be explicitly told that participation in the study is completely voluntary and participation or withdrawal from the 
study will not influence their work or academic progress. All data will be de-identified and only the researchers 
will have access to this. 
 
3. With reference to the inclusion criteria for the study, it would seem sensible to exclude those who 
are known to be anaemic, given the volume of blood required.  Please would you also explain 
when and by whom a medical history would be taken and how ‘mental health problems’ would be 
assessed as an exclusion criterion?  It is also not clear whether those who score high on the 
Fatigue Severity Scale would be excluded from taking part in the study.  Please would you clarify 
this point?   
 
We will recruit 15 healthy controls who are between 20-60 years old. With no pathology known to 
influence immune response ( e.g. Auto immune diseases, anaemia, heart diseases, orthopaedic 
limitations or renal failure disease) by using the Physical Activity Readiness-Questionnaire  PAR-Q, pre-
screening health questionnaire and medical history  to  determine the safety or possible risk of exercising 
for an individual based upon their answers to specific health history questions. We will exclude 
participants with a mental health problems by asking them (Are you been treated for any mental health 




4. Please justify the need to collect 9 ml blood on each occasion.  This seems excessive to measure 
cytokine and exosome concentrations in plasma, particularly as this analysis is confined to 
exosome variation only on day 1.   
 
Day 1 is a monitoring day of natural variation of exosomes during a day. Firstly, a blood sample 
(6mls need to be collected  as after remove all cells we end up with approxiamtely 2,5 mls of 
plasma ), In which we will use that amount of plasma for exosomes analysis. 
 
5. The burden on research participants is high i.e. the study is time consuming and requires frequent 
blood samples totalling approximately 200 ml.  Given this, it would seem necessary to offer an 
incentive / reward.  Failing to do so may adversely affect recruitment.    
 
Participants in this study will  receive a £10 book voucher at the end of the study, also they will be 
offered  lunch and refreshments during the study. 
 
6. Please would you clarify how participants would be occupied during the 10-hour experiment?  
Would they receive lunch and refreshments and, if so, who will provide this?    Yes they will 
receive lunch and refreshments. 
 
7. Please clarify whether resuscitation equipment is available in the lab where the exercise will take 
place.     
 
However, resuscitation equipment will be available in the lab where the exercise will take place. In 
addition, participants will be screened before starting exercise experiment and they will be made 
aware that they are free to withdraw from the study or stop any activity at any point without giving a 
reason. Moreover, participants will be advised not to donate blood for at least 7 days from the end 
of this study. 
 
8. It is unclear why a questionnaire entitled ‘Physical activity in the elderly’ is being used for data 
collection in a population aged 20-60 years. If the validity of the data collection instrument is 
questionable, it is unethical to ask participants to complete this.  Similarly, the relevance of the 
visual analogue scale and the vitality scales to the research question is unclear.  Please would you 




Physical activity level questionnaire (PASE ), this was adapted and validated for use in young 
adults and this questionnaire is appropriate and valid for Multiple Sclerosis (MS) which i will 
conduct the same study on them after healthy participants. Also, Visual Analogue Scale (VAS), to 
measure changes in muscle soreness which caused by strenuous exercise. 
9. It is not clear whether the research data would be retained for 20 years (as per E2U) or for 
10 years (as stated in the participant information sheet).   
Study data will be kept according to MRC guidelines and stored for 20 years.       
 
10. A number of amendments are required to the participant information sheet: 
a. Individuals have been invited to take part because they are members of staff / or are 
students within the Movement Science Group, not because they meet specific 
eligibility criteria.    
You have been invited to participate because you are a healthy member of staff/ or a student 
with no history of autoimmune disease, heart attack, renal failure, or mental health problems, 
anaemia and you are over the age of 18 years. 
b. It is unclear whether participants are required to fast and abstain from drinking 
alcohol and exercise prior to taking part (as stated in the PAR-Q).  If so, this should 
be clearly stated in the information sheet.   
                      You will be required to fast and abstain from drinking alcohol and any strenuous exercise 
prior to                          taking part in the study. 
c. The information appears incorrect regarding the number of questionnaires for 
completion on day 2. 
In the second session (which will be one week after the first session), we will collect a blood sample from 
your arm vein (9 mls), then you will be asked to fill in 3 questionnaires that should take about 5 mins. 
 
d. Please explain the intended course of action if the researcher is unable to obtain 
blood.   
e. Over the course of the study, 20 blood samples [not 10] would be taken. 
If there is any difficulties obtaining blood or if we had two missing blood draw, we would stop 
at that point, and we will not ask them to return for day 2.  If blood obtained at time 0, then is 
most likely blood can be drawn up until the end of first 6 hours. If fails at the 2 extra 
venepuncture (at hours 8 and hours10), we will not ask the participant to come back for any 
more blood draw. 
 
f. It would seem unnecessary to state that a risk of taking part is infection.  Proper 
aseptic precautions during phlebotomy should remove this risk.   
Taking blood samples can cause local bruising or fainting in certain individuals. Every precaution will be 
taken to reduce the chances of these side effects – samples will be taken by a fully qualified individual 
using a sterile syringe and needle. You will be asked to sit or lie down during the procedure to reduce the 
chance of fainting.  
 
g. The ‘step up and weight protocol’ should be clearly explained.  The information sheet 
contains no reference to the use of weights.   
After that we will ask you to undertake an exercise test (a step up and down test for approximately 15 
minutes). During the exercise test, you will ask to perform 20 up and down steps for each leg with a 
weight of 10Kg for each hand, in which this will be the first set. A 2 mins rest between each set for a total 
of 5 sets, you will be asked to wear a heart rate monitor. Every two minutes we will ask you how you feel. 
At this point you will be completed the exercise test for this study.  
 
h. Explain that those who take part would be ineligible to donate blood for at least a 
week beyond the end of the study.   





i. As the legal limitations to data confidentiality do apply, please explain that 
confidentiality can only be protected within the limitations of the law. .  
 All data collected will be de-identified and confidentiality will be protected within the 
limitations of the law.   
 
j. The information sheet contains numerous typographic errors requiring correction.  
This should be checked by the Supervisory team.       
11. Consent form – Please clarify the wording of clauses 5 and 6.  As currently presented they 
could be interpreted as contradictory.   
 
I have been informed that all samples collected will be destroyed and not used for further 
research. 
I agree for the anonymised data obtained from samples may be stored and used in other 
research Y NO 
 
I attach all modified documents to include the E2U, participant information sheets and consent form,  
 
 
Many thanks  
 
Eman Abu Seer 
 
Hazel Abbott 
Chair of the University Research Ethics Committee 
 
cc    Dave Carter and Ryan Pink, Supervisory Team 
       Eman Abu-Seer, Research Student 
       Dido Green, Research Ethics Officer 
       Jill Organ, Graduate Office 
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Mrs Hazel Abbott 
Chair of the University Research Ethics Committee 
University Research Ethics Committee 
Marston Road Campus 
Oxford Brookes University 
 
 
Dear Mrs Abbott, 
Ethics Amendment UREC 130712; The influence of strenuous exercise on the 
inflammatory process in healthy participants 
 
I respectively request an amendment to the original ethical approval application for the 
above stated study. 
 
Since starting this study, we have found that there may be significant variation in 
exosomes levels and other inflammatory markers levels in response to strenuous 
exercise. Whereas exosomes and cytokines levels did not appear to markedly change 
over a normal day. In order to confirm that these findings, we not due to day- to-day 
variation. 
 We would like to add in additional collection of bloods over five consecutive days. Only 
one blood sample (4ml) will be drawn from the participants in the morning over five 
consecutive days. 
This information is vital to understand the natural day- to- day variation of exosomes 
secretion and attribute an exercise response.  We aim to explore day to day variability 
within the same person by measuring exosomes levels same time of the day over five 
consecutive days. 
 
Additionally, I have added the aim of this amendment into Participant Information Sheet 
(3. What is the purpose of the study?). I also have made reference to the approved 
study in the consent form. I have clarified the amendment by considering the two 
different phases of the study 1) inflammatory response to exercise 2) natural variation 
of exosome ???,   
In the event that individuals have already completed Phase 1, recruitment to Phase 2 
will follow the same process but previous participants would only undertake Phase 2.  
They will be asked to sign informed consent (eg. provided with the updated PIS and 
had time for questions) for the amended protocol. 
Changes have been highlighted in yellow. 
 
I hope that this information is sufficient to grant us a minor amendment to the study. 
 



















Ethics approval number: 
 
1. Study Title 
The influence of strenuous activity on the inflammatory process in healthy participants. 
 
2. Invitation paragraph 
You are being invited to take part in a research study.  Before you decide whether to take part it 
is important for you to understand why the research is being done and what it will involve.  Please 
take time to read the following information carefully and discuss it with friends, relatives and your 
GP if you wish.   
 
• This information sheet, tells you the purpose of this study and what will happen to you if 
you take part.   
Please ask us if there is anything that is not clear or if you would like more information.  Take 
time to decide whether or not you wish to take part. 
Thank you for reading this. 
 
3. What is the purpose of the study? 
The aim of this study is to understand how the immune system responds to exercise. As several 
studies have reported that exercise is good for health and the wellbeing, we aims to explore the 
immune system and mechanism of inflammation by looking at small vesicles in the blood. In order 
to do this work we need to obtain 20 blood samples over a certain time period which would be in 






4. Why have I been invited? 
You have been invited to participate because you are a healthy member of staff/ or a student with 
no history of autoimmune disease, heart attack, renal failure, or mental health problems, anaemia 
and you are over the age of 18 years.  
 
 
5. What will happen to me if I take part? 
If you decide to take part you will be asked to sign a consent form for this study. A suitable time 
for you will be arranged to come to the movement science lab at Oxford Brookes University. You 
will be required to fast and abstain from drinking alcohol and any strenuous exercise prior to 
taking part in the study. Then you will be asked to attend two sessions. In the first session, we will 
ask you about your medical history, and we will ask you to complete a pre-screening health 
questionnaire (PAR-Q) to ensure your eligibility for the study. After that, we will collect a blood 
sample from your arm vein (6 mls) and we will keep the cannula in your arm and stabilize it by a 
medical tape. Afterwards, we will ask you to complete 3 questionnaires that should take about 10 
minutes. Following this, we will collect blood samples from the butterfly cannula every one for 
the first six hours. After that we will remove the cannula from your arm and we will collect another 
two blood samples (one sample at hours 8.00 and one sample at hours 10.00) by venepuncture. A 
total of 60 mls blood will be taken from you over 10 hours. 
 
 In the second session (which will be one week after the first session), we will collect a blood 
sample from your arm vein (9 mls), then you will be asked to fill in 3 questionnaires that should 
take about 5 mins. After that we will ask you to undertake an exercise test (a step up and down 
test for approximately 15 minutes). During the exercise test, you will ask to perform 20 up and 
down steps for each leg with a weight of 10Kg for each hand, in which this will be the first set. A 
2 mins rest between each set for a total of 5 sets, you will be asked to wear a heart rate monitor. 
Every two minutes we will ask you how you feel. After completed the exercise test, we will collect 
a post exercise blood sample (9 mls) from your arm vein by a butterfly cannula and we will keep 
it in your arm and stabilize it by a medical tape. We will collect blood samples by drawing blood 
from the cannula every one hour for the first six hours. After that we will remove the cannula from 
your arm and we will collect another two blood samples (one sample at hours 8.00 and one sample 
at hours 10.00) by venepuncture. A total of 100 mls blood will be taken from you over 11 hours. 
  
At this point your involvement in the study will be completed.  All data collected will be de-
identified and confidentiality will be protected within the limitations of the law. If you are a 
student or staff, your decision to take part or not will not affect your program of studies or 
employment, respectively. You are free to withdraw from the study at any point or stop an activity 
without giving a reason. 
  
 
6. What are the side effects of taking part? 
Taking blood samples can cause local bruising or fainting in certain individuals. Every 
precaution will be taken to reduce the chances of these side effects – samples will be taken by a 
fully qualified individual using a sterile syringe and needle. You will be asked to sit or lie down 
during the procedure to reduce the chance of fainting.  
 
7. What are the other possible disadvantages and risks of taking part? 
Taking part in the exercise may cause you to feel out of breath or some muscle discomfort. 




questionnaires; we also will take your blood pressure before stating the exercise test. Moreover, 
there will be qualified individuals with first aid qualification on site at all the times.  
 
 
8. What are the possible benefits of taking part? 
There is no direct benefit to you, but we hope this study will improve our understanding of the 
response of immune system to inflammation to acute/strenuous exercise. 
 
9.  What will happen to the information/results collected in the project? 
All the information about your participation in this study will be kept confidential. All data will 
be de-identified. All blood samples will be processed to remove cellular tissue within 24 hours in 
our facility labs at Oxford Brookes University and samples destroyed after processing. Protein 
samples will not have your name or any personal data attached so that you cannot be identified 
from the samples or the data produced from it. Only members of this research project will have 
access to any samples collected. No samples will be transferred outside of the UK and samples 
will not be used for any future research.  
All information that is collected about you during the course of this research will be kept strictly 
confidential. All the samples will be analysed anonymously. All procedures for handling, 
processing, storage and destruction of your data are compliant with the Data Protection Act 1998. 
Furthermore, all data generated by the study must be retained in accordance with the University’s 
policy on Academic Integrity, and that it must be kept securely in paper or electric form for a 
period of 20 years after the completion of a research project. 
 
 
   
 
10. What will happen to the results of the research study? 
Data generated from this study may be used in scientific publications and is part of a PhD project. 
If you wish, we can inform you of any publications that are generated in the course of this study. 
Also, a summary of the study which will be made available on the movement science group 
website in December 2013. 
 
 
11. Type of study? 
A PhD research project. 
 
12. Who is funding the research? 
This study would be funded by the Royal Embassy of Saudi Arabia. 
 
13. Ethical approval 
 
 
14. What if there is a problem? 
If you have any concerns about the conduct of the research, you could contact the Chair of 
University Research Ethics Committee on ethics@brookes.ac.uk. 
 
 
15. Contact Details: 





Email: 11103599@brookes.ac.uk  
Address: Movement Science group, School of Life Sciences, Oxford Brookes University,  
Gipsy Lane Campus, Headington, OX3 0BP 
Name of supervisor: Prof Helen Dawes 
Telephone: 01865 483272 
Email: hdawes@brookes.ac.uk 
Address: S306j, School of Life Sciences, Oxford Brookes University,  
Gipsy Lane Campus, Headington, OX3 0BP 
   
 
16. Who else can I contact regarding this study? 
 
Prof Helen Dawes 
 
Telephone: 01865 483272 
 
Email: hdawes@brookes.ac.uk   
 
Dr Dave Carter 
Telephone: 01865484216 
Email: dcarter@brookes.ac.uk 
Dr Ryan Pink 
Telephone: 01865 484187 
Email: rpink@brookes.ac.uk 
 
Dr Johnny Collett 









If you would like to take part, please complete the tear-off reply slip below: 
 
 










Appendix C: pre-screening health questionnaire 
Age:…………………………..yrs 
Weight:    kg Height:  m  cm 
Blood pressure: 
Systolic  mmHg  mmHg  mmHg Diastolic 
  mmHg   mm Hg  mmHg 
Prescribed medication use: 
 
Name drug Dosage Time of day Date of change 
    
    













      
 
Questionnaire FSS PAR-Q FASE SF-36 
     
 
Visual Analogue Scale 
 
0 10 
No pain Worst pain ever 
Please indicate on this line how sore you feel  
End Test 
Blood Sample Lactate BP 
Sys/dia 
VAS Separate and 
store serum at 
(-80°) 
Baseline (0 hour)     
Immediately 
after the exercise 
    




2 hours     
3 hours     
4 hours     
5 hours     
6 hours     
8 hours     
10 hours     




Visual Analogue Scale (After exercise) 
 
0 10 
No pain Worst pain ever 
Please indicate on this line how sore you feel 
LAB TEST (ELISA) 
TEST TNF-α IL-6 IL-10 




EXO EXTRACTION EXO GRID PREPRATION 
FOR  EM 
EXO PREPRATION FOR 
NANOSIGHT 




Physical Activity Readiness-Questionnaire (PAR-Q) 
Please read the following carefully and answer as accurately as possible by ticking the appropriate 
box for each question. 
                                                                                    Yes               No 
1. Has a doctor ever said you have heart trouble?   
2. Do you ever suffer frequently from chest pains?   
3. Do you often feel faint or have spells of dizziness?   
4. Has a doctor ever said you have epilepsy?   
5. Has a doctor ever said you have high blood pressure?   
6. Has a doctor ever said you have diabetes?   
7. Has a doctor ever said you have asthma?   
8. Do you have a bone, joint or muscular problem which 
may be aggravated by exercise?   
9. Do you have any form of injury?   
10. Are you currently taking any prescription medications?   
11. Have you suffered from a viral illness in the last two 





 Yes No 
Have you eaten anything within the last hour?   
Have you consumed alcohol within the last 24 hours?   
Have you performed exhaustive exercise within the last 48 hours?   
 
If you have answered YES to any of the above questions, or know of any possible reason (physical 
or psychological) that might affect the safety or accuracy of the tests - please inform a member of 
staff. 





General Health Status Questionnaire (SF-36) 
This survey asks for your views about your health. This information will help keep track of how 
you feel and how well you are able to do your usual activities. 
Please answer these questions by “check-marking” your choice. Please select only one choice 
for each item. 
1. In general, would you say your health is: 
◻ 1. Excellent   2. Very good   3. Good   4. Fair   5. Poor 
2. Compared to ONE YEAR AGO, how would you rate your health in general NOW? 
◻ 1. MUCH BETTER than one year ago. 
◻ 2. Somewhat BETTER now than one year ago. 
◻ 3. About the SAME as one year ago. 
◻ 4. Somewhat WORSE now than one year ago. 









3. The following items are about activities you might do during a typical day. Does your 
health now limit you in these activities? If so, how much? 
Activities 1. Yes, Limited 
A Lot 
2. Yes, Limited 
A Little 
3. No, Not 
Limited At All 
a) Vigorous activities, such as running, 
lifting heavy objects, participating in 
strenuous sports? 
1. Yes, Limited 
A Lot 
2. Yes, Limited 
A Little 
3. No, Not    
Limited At All 
b) Moderate activities, such as moving a 
table, pushing a vacuum cleaner, bowling, 
or playing golf? 
1. Yes, Limited 
A Lot 
2. Yes, Limited A 
Little 
3. No, Not 
Limited At All 
c) Lifting or carrying groceries? 1. Yes, Limited 
A Lot 
2. Yes, Limited 
A Little 
3. No, Not 
Limited At All 
 
d) Climbing several flights of stairs? 
1. Yes, Limited 
A Lot 
2. Yes, Limited 
A Little 
3. No, Not 
Limited At All 
e) Climbing one flight of stairs? 1. Yes, Limited 
A Lot 
2. Yes, Limited 
A Little 
3. No, Not 
Limited At All 
f) Bending, kneeing or stooping? 1. Yes, Limited 
A Lot 
2. Yes, Limited 
A Little 
3. No, Not 
Limited At All 
g) Walking more than a mile? 1. 1. Yes, Limited A 
Lot 
2. 2. Yes, Limited A 
Little 
3. No, Not 




h) Walking several blocks? 1. 1. Yes, Limited 
A Lot 
2. 2. Yes, Limited 
A Little 
3. No, Not 
Limited At All 
i) Walking one block? 1. 1. Yes, Limited 
A Lot 
2. 2. Yes, Limited 
A Little 
3. No, Not 
Limited At All 
j) Bathing or dressing yourself? 1. 1. Yes, Limited 
A Lot 
2. 2. Yes, Limited 
A Little 
3. No, Not 
Limited At All 
 
4- During the past 4 weeks, have you had any of the following problems with your work or other 
regular activities as a result of your physical health? 
a) Cut down on the amount of time you spent on work or other 
activities? 
 1. yes  2. No 
b) Accomplished less than you would like?  1. yes  2. No 
c) Were limited in the kind of work or other activities?  1. yes  2. No 
d) Had difficulty performing the work or other activities (for example it 
took extra effort)? 







5. During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of any emotional problems (such as feeling depressed 
or anxious)? 
a) Cut down on the amount of time you spent on work or other 
activities? 
 1. yes  2. No 
b) Accomplished less than you would like?  1. yes  2. No 
c) Didn’t do work or other activities as carefully as usual?  1. yes  2. No 
 
6. During the past 4 weeks, to what extent has your physical health or emotional problems 
interfered with your normal social activities with family, friends, neighbours, or groups? 
◻ 1. Not at all 
◻ 2. Slightly 
◻ 3. Moderately 
◻ 4. Quite a bit 




7. How much bodily pain have you had during the past 4 weeks? 
 1. None 
 Very mild 
 3. Mild 
 4. Moderate 
 5. Severe 
 6. Very severe 
 
8. During the past 4 weeks, how much did pain interfere with your normal work (including both 
work outside the home and housework)? 
 1. Not at all 
 2. A little bit 
 3. Moderately 
 4. Quite a bit 





9. These questions are about how you feel and how things have been with you during the past 4 
weeks. For each question, please give the one answer that comes closest to the way you have been 
feeling. How much of the time during the past 4 weeks 
 1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 
6. None of 
the time 
a) Did you feel full of 
pep? 
1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 
6. None of 
the time 
b) Have you been a very 
nervous person? 
1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 
6. None of 
the time 
c) Have you felt so 
down in the dumps that 
nothing could cheer you 
up? 
1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 
6. None of 
the time 
d) Have you felt calm 
and peaceful? 
1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 
6. None of 
the time 
e) Did you have a lot of 
energy? 
1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 
6. None of 
the time 
f) Have you felt 
downhearted and blue? 
1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 





g) Do you feel worn 
out? 
1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 
6. None of 
the time 
h) Have you been a 
happy person? 
1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 
6. None of 
the time 
i) Did you feel tired? 1. All of the 
time 
2. Most of 
the time 
3. A good 
bit of the 
time 
4. Some of 
the time 
5. A little of 
the time 
6. None of 
the time 
 
10. During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting with friends, relatives, etc.)? 
 1. All of the time 
 Most of the time. 
 3. Some of the time 
 4. A little of the time. 







11. How TRUE or FALSE is each of the following statements for you? 
 




























































































Appendix E: Comparing of average exosome concentration in eccentric and moderate 















The Reliability of Plasma Exosome Concentrations 
in Healthy Male Individuals 
 
Eman Abu-Seer  
Oxford Brookes University, Gipsy Lane, Oxford, OX3 0BP, UK 
 
Abstract: Exosomes are nanometer sized vesicles (30-100 nm), released from cells following the fusion of multivesicular bodies with 
the plasma membrane. Exosomes have a major role in intracellular communication, immune response modulation, physiological and 
pathological functions, and an important use in different drug therapies. Moreover, they have been identified as potential biomarkers 
and are involved in cancer and many other disease processes. Despite the developments in this area, no studies exist that assess the 
variability of plasma exosomes measures within and between subjects. The purpose of this study was to assess within and between day 
variability of plasma exosomes concentration in healthy individuals. Also, the stability of exosomes during freeze/thawing cycles was 
measured in this study. Eleven healthy men were assessed for reliability of exosome concentrations taken over the same sampling 
period, over 10 hours of a day and over five days. Exosomes were isolated by differential ultracentrifugation and characterized by their 
size distribution and morphology by electron microscopy and using the Nanosight tracking analysis respectively. Mean plasma 
exosome values were1.505-2.245 × 10^8/mL). Within day variability was not significantly different (P = 0.95), and between day 
variability was not significantly different (P = 0.42). The interclass correlation coefficients (ICC) of 0.80 for within sample showed 
good reliability; ICC of 0.84 for between day plasma exosomes concentrations showed good reliability, and the within day ICC of 0.70 
showed a moderate reliability. There was no significant difference observed in using fresh or frozen plasma in exosome quantification 
or exosome concentration. The statistics show that there is little significant variability in plasma exosome concentrations taken over a 








In normal cell’s physiology, there is constant transport 
of biological materials across the cellular membranes. 
This transport works according to an evolutionary 
conserved mechanism and involves active and passive 
modes of transport along with the trafficking through 
micro particles, vesicles produced by the cell, including 
exosomes [1]. Exosomes are under the scientific spotlight 
as important methods of extracellular excretions and are 
nanometer sized vesicles (30-100 nm), released by cells, 
both normal and cancerous, into the extracellular space by 
inward budding of endosomal membrane into structures 
called multi-vesicular bodies (MVBs), followed by fusing 
of  
 
Corresponding author: Eman Abu-Seer, research field:  
clinical trials. 
MVBs with the plasma membrane and release their 
internal component (exosomes) extracellularly [2]. They 
are composed of nucleic acid and protein and have been 
largely attributed to be the carriers of these constituents to 
various parts of the body without any discrimination. 
However they are also widely known to carry 
intercellular messages, effects of and signalling 










first reported by Johnstone and his colleagues in 1987, 
when they found that exosomes are secreted from 
reticulocytes during maturation [3]. Exosomes can be 
released by many cells, such as T-cells, dendritic cells, 
and oligodendrocytes cells and non-hematopoietic cells 
such as neuroglial cells, tumour cells and intestinal 
epithelial cells [4]. They have been detected in several 
biological fluids as plasma, saliva, nasal lavage, placenta, 
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interesting in many applications for example the 
plasma levels in some cancer patient could be a 
potential tool for cancer screening [6]. 
 
1.2 Exosomes as Potential Biomarkers in Cancer 
Identification and Development 
 
It has been largely hypothesized that since the 
exosomes carry a particular cellular content, they can be 
exploited as potential biomedical tools to detect the 
changes in the content of the cells, as in the initiation and 
progression of cancer or tumorous growths. The micro 
ribonucleic acid content of the exosomes corresponds to 
only particular cell types and are attributed to changing 
the phenotype of the progenitor cells by effectively 
transferring pro-oncogenic molecules in order to initiate 
the growth of cancers in these cells and hence give rise to 
metastatic environment in the neighbouring cells [7]. It 
has been suggested that increased level of exosomes can 
be detected in urine, serum, and in malignant effusions 
from cancer patients [8]. Kharaziha, Ceder [9] reported 
that cancer cells secrets higher amounts of exosomes than 
normal cells. Furthermore, Taylor and Gercel-Taylor 
[10]found that cancer patients have excessive amounts of 
blood circulating exosomes compared to healthy 
individuals. Therefore, the number of exosomes is 
important and can be used as markers in many diseases 
including cancer. Logozzi, De Milito [6] study shows high 
levels of exosomes that expressed CD63, housekeeping 
protein present in all human beings nonetheless, and 
Caveolin-1, tumour-associated biomarker, in the plasma 
of cancer patients. ELISA was used for quantifying the 
levels of exosomoes present in the plasma of the cancer 
patients that expressed the two proteins and it was found 
that the levels for CD63 and Caveolin-1 were significantly 
increased in melanoma patients as compared to the 
healthy individuals who donated plasma. Therefore, the 
analysis of exosomes for specific tumour-biomarkers can 




metastasized tumour and causes mortality [6]. 
Furthermore, Ren and colleagues were able to show 
that exosomes present in human plasma displayed a 
variety of shapes and exhibit the exosome marker 
protein CD81 besides CD63, along with other members 
of MHC Class II including CD86, Wnt3a, Wnt5a and 
FasL which are normally known as the cell signal 
transduction molecules [11]. Plasma exosomes were 
also shown to participate in the inhibition of CD4+ T 
cells involved in the immune system. They possess the 
ability to induce suppression, in dose-dependent 
manner, of the active CD4+ T cells and their 
proliferation in the plasma, leading to their natural 
apoptosis in the body [11]. Moreover, Salma Khan and 
colleagues researched on the levels of Exosomal 
Survivin in patients with prostate cancer and in control 
patients, derived from their plasma. Survivin is 
expressed in the plasma of patients diagnosed with 
prostate cancer and it is important for making the PCa 
cells sensitive to the chemotherapeutic agents. Its 
downregulation causes the effective eradication of the 
cancerous cells at the end of chemotherapy. The recent 
research in the exosomes has shown that the exosomes 
derived from the tumour, much like the ones derived in 
this experiment, help drastically in the initiation and 
development of cancer in the cells affect as well as help 
it metastasize to other parts of the body. Exosomes were 
purified from serum and plasma samples from PC 
patients as well control population  
using the experimental techniques of 
ultracentrifugation and ELISA and Western blotting 
were used to quantify the amount of exosomes present 
in the samples isolated. It was found to be present in 
elevated levels in the tumour-derived samples as 
compared to the serum and plasma exosome levels in 
the control patients. The patients who had failed to 
respond to chemotherapies also projected increased 
levels for exosome-derived Survivin. Therefore, the 
researchers were successful in showing that Survivin 
exists in the plasma and serum-derived exosomes in 
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elevated amounts and can be used as a potential 
biomarker in early detection of cancer [12]. 
 
1.3 Additional Functions of Exosomes 
 
In addition to the interest in exosomes as potential 
biomarkers, their physiological roles are also important 
which basically deal with the pathways related to 
intracellular and intercellular communications. They play 
a crucial role in cell to cell communication when they 
interact with other cells by carrying proteins, lipids, and 
genetic information [13], whether the cells present locally 
or at a distance. They have been found to be involved in 
immune regulation and act as antigen-presenting vesicles, 
the behaviour commonly found in the B and T immunity 
cells, in order to stimulate the immune response and 
induce tolerogenic effects [13-15]. Also exosomes have 
been involved in 
 
some diseases’ pathogenesis such as neurodegenerative 
disease and cardiovascular disease  
[16]. It has been shown that exosomes are involved in 
the accumulation of β-amyloid protein which is 
associated with Alzheimer’s’ disease [8].  
Recently a wide range of exosomes physiological and 
pathological function studies have been conducted. 
Although the number of studies examining plasma 
exosomes is increasing, however, there is a need to 
better understand the variables that affect exosomes 
levels and the mechanisms that control the production 
and mediation of exosome levels. Also there might be 
variation in between subjects over a day and within a 
day. Although, circadian variations are often detected 
on human immune biomarkers and have been studied. 
For example, the study conducted by Ündar, Ertugùrul  
[17] reported a significant circadian variation in 
different blood biomarkers (IL-6, coagulation 
inhibitors proteins, and anti-thrombin factors in 
healthy men [17]. However, exosomes’ circadian 
rhythm in healthy individuals is still unknown.  
It is important to know the variability in measuring 
exosome numbers and size. The variability can help 
point towards the variety of roles that exosomes 
  
perform in the various parts of the human body in their 
multiple morphological orientations as demmed 
appropriate and essential based on the biochemical 
environment inside and outside the cells. Further which 
measurement bias in the data affects the measurement 
variability, which can occur in pre-analytical (specimen 
collection, handling and processing), analytical 
(imprecision and bias), and post-analytical (interpreting 
and reporting data) data sets [18]. Gardiner, Ferreira 
[19] examined the analytical measurement variation of 
exosomes measures processes by Nano sight Tracking 
Analysis (NTA). It is essentially a technique where the 
light is scattered by the subjects in focus which leads to 
the specification of their size and quantity present in a 
sample. They used silica microspheres in order to 
calibrate the measurements taken by the technique as 
standardized method for extra-vesicles (exosomes) 
measurements, in order to decrease the level of 
inaccuracy associated with the measurements. Gardiner, 
Ferreira [19] showed data from several repeat 
measurements of known concentration. However, a 
biological standard for exosomes measurement has not 
been studied and the within-subject variations have not 
been addressed. The additive features of the technology 
are distributed across five distinct levels. Primarily, it 
allows for determining the detection threshold which 
refers to the minimum value for the intensity of an 
image that can help distinguishing a particle for further 
analysis. Furthermore, the technology can help in 
determining the maximum distance that the software 
expects a particle to move from one frame of reference 
to another. This is directly proportional to the size of the 
particle and therefore, the larger particles would take 
longer to move across the frames. This minimum 
expected particle size is automatically determined by 
the software. Moving on, blur which defines the degree 
of smoothing of the images received by the software 
after removing the unrequired noise, including 
predominantly the diffraction rings found around the 
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larger particles, is another automatic setting built into the 
software. It can be manually adjusted to increase for 
bigger particles and decrease for the smaller ones. 
Moreover, it also determines the minimum track length 
that a particle should cover based on its size for it to be 
included in the size distribution plot. This plot is entirely 
based on the Mean Square Displacement (MSD) profile 
for all the particles and which have been tracked for a 
minimum number of frames as determined by the machine 
automatically or set manually by the scientific researcher. 
Higher values for minimum track length mean that the 
particles have been tracked for a greater length of time 
which helps in accurate sizing of all the particles under 
scrutiny. However, it does not imply that the particles that 
spend less time in crossing one frame of reference to 
another are measured inaccurately. It can also mean that 
these particles are smaller in size and hence, take less time 
to get across the threshold. Lastly, the background noise 
or pixel contamination can be easily removed from the 
extracted data sets or images in order to make the readings 
as accurate as possible for the size of the particles. 
Therefore, Nanoparticle Tracking Analysis can be 
successfully employed to determine size of the biological 
molecules such as exosomes to develop the importance of 
their molecular physiology to the function they perform 
[19]. 
 
Considering physiological and pathological 
importance of exosomes as potential biomarkers for 
neurodegenerative diseases and multiple cancer types, 
there exists a further need for reliability measures of 
plasma exosomes concentration in plasma, thereby 
leading to reliable and accurate prognosis of disease 
initiation and development. In conjunction to their 
need, the day-to-day variation in the readings should 
also be well accounted for and measured accurately to 
understand their association with changing 
biochemical environment in the body and how the 
exosomes can help as effective tools in marking these 
changes at early stages. This will help to determine 
whether a single fasted blood sample is sufficient or if 
 
 
consecutive day blood samples are needed to present an 
individual’s exosomes status. Therefore, the purpose of 
this study is to assess within and between day reliability 
of plasma exosome concentration. We hypothesized 
that plasma exosomes concentration should be stable 
within sample, although there might be little within day 
variability, however the overall plasma exosome 
concentration is found to be stable over the period of 
five days of blood sampling in a week. 
 
1.4 Aims and Objectives of the Study 
 
The main aim of this study is to explore reliability of 
plasma exosomes in healthy individuals. There are 
other objectives of the study: 
 To assess within sample, within day and between 
days variability of plasma exosome concentrations 
 To predict the size distribution for a given population 
of extracellular vesicles within a day at different time 
points and also between days over five consecutive 
days in healthy individuals. 
 To determine the stability of exosomes during 
freeze/fresh plasma. 
Although, circadian variations are often detected on 
human immune biomarkers. We hypothesized that 
plasma exosomes concentration should be stable within 
sample; there would be little day to day variability in 







Eleven healthy male participants (age 27.6 ± 4.2 y, 
height, 177.0 ± 9.4 cm, and body weight, 80.3 ± 12 kg) 
volunteered to participate in the study which was 
approved by the University Research Ethics 
Committee. This study conformed with the latest 
revision of the Declaration of Helsinki. All procedures 
and potential risks associated with the study were fully 
explained to each participant. All participants reported 
to the human performance laboratory and answered 
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screening questionnaires to determine their eligibility for 
the participation in the study. Participants were eligible 
for inclusion if they were healthy male and between 20 
and 60 years of age. Exclusion criteria included diagnosis 
of a chronic inflammatory condition (e.g diabetes mellitus 
and cardiovascular diseases or recent consumption of anti-
inflammatory medications (e.g ibuprofen). Since the 
scope of the study is to study the variation found in the 
levels of exosomes or their concentration in healthy 
individuals, therefore the indication of any inflammatory 
condition refers to the natural increase in the 
concentration of exosomes and any proteins that are 
associated with anti-inflammatory response [20]. 
Moreover, subjects were excluded if they had any 
pathology known to influence immune response (e.g. 
Auto immune diseases, anaemia, heart diseases, 
orthopaedic limitations or renal failure disease), or 
neurological, neuromuscular disorder. Subjects who had 
any cold or flu symptoms in the previous 24 h were 
excluded from the study based on the same explanation as 
provided earlier about the natural increase in the level of 
exosomes in cases of inflammatory response. 
 
2.1.1 Sample Size  
This is part of another study (exosome and 
inflammatory markers (TNF-a, IL-6, IL-10) in healthy 
individuals before and after high/low intensity exercise), 
in which the same sample size calculation was also used 
in this study. The sample size calculation is based on data 
from a review which has been done by [21], based on 
cytokines (TNF-a, IL-6, IFN-γ) measurement between 
healthy and healthy group. With an effect size of 0.55, the 
power of this study is set at 80%, and the level of 
significance is set at 5% (0.05, two tailed-analyses). Also 
we used sample size of 11 individuals based on a previous 
study by [22], which looked at changes in muscle RNAs 
in response to acute and chronic aerobic exercise.  
2.1.2 Within Sample  
For all studies, during each visit individuals were 
asked to fast for 8 to 10 hours before blood draws and 
  
refrain from alcohol for 24 h, and an exhaustive 
exercise for 48 h before each visit. They were allowed 
to drink water only. In order to determine whether the 
method of extracting exosomes were reproducible 
during each visit, three blood samples (4 mL each) were 
drawn consecutively from the antecubital vein into 
EDTA vacutainers (Becton Dickinson; San Jose, 
California). Then blood sample was centrifuged at 
1,000 g for 10 min at 4 ºC, plasma was separated, 
divided into 500µ aliquots and subsequently stored at -
80 ºC. The exosomes were then processes as below.  
2.1.3 Within Day Reliability  
In order to assess within day reliability, the same 
eleven individuals were participated in this study. In 
this visit, the first fasted blood sample was drawn by 
venepuncture using a winged infusion device at the 
baseline 0 h. Then blood sample (4 mL) was drawn at 
1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 8 h, and at 10 h. Participants 
were offered a standardized diet after the second hour 
and the sixth hour from the beginning of the study. All 
blood samples were collected, and processed as stated 
above.  
2.1.4 Between Day Reliability  
In order to examine plasma exosomes reliability 
between multiple days, same eleven participants 
reported to the laboratory five times over five 
consecutive days. During each visit blood sample (4 
mL) was drawn at the same time from every participant. 
All blood sample were processed same as stated above. 
 
2.2 Study Design 
 
2.2.1 Preparation of Plasma Exosomes  
Exosomes were isolated by differential 
ultracentrifugation. Basic exosomes isolation protocol 
was followed as described by [23]. Plasma sample was 
separated from blood and diluted with an equal amount 
of PBS and gently mixed until homogenous. Then the 
mixture was transferred in 50-mL tubes, centrifuged for 
30 min at 2,000× g, 4 °C followed by at 12,000 g for 45 
min. The suspension was filtered 
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through a 1% BSA blocked 0.22-µm filter, collected in 
a fresh ultracentrifuge tube, and centrifuged for 2 h at 
110,000× g, 4 °C in a Beckman LE-80K centrifuge, 
swing out rotor (Beckman Coulter Optima, SW 32 Ti). 
Subsequently the pellet was washed in PBS by filling up 
a 14 mL tube with PBS and then centrifuged at 
110,000× g, 4 °C for 70 min. After, the pellets were re-
suspended in 50 µ PBS, and stored at -80 °C.  
Exosomes were immediately isolated from the first 
aliquted samples (A) by differential ultracentrifugation 
and then examined morphologically by electron 
microscopy. The number of exosomes were analysed 
by Nanosight tracking analysis. The second plasma 
samples (B) were 
 
2.3 Exosomes Analysis 
 
2.3.1 Stability of Plasma Exosomes  
To determine the stability of exosomes during 
freeze/fresh plasma (5 mL) from eleven healthy 
individuals were collected and divided into two 2.5 mL 
samples. Then exosomes were immediately isolated 
from the first aliquted samples (A) by differential 
ultracentrifugation and then examined morphologically 
by electron microscopy. The number of exosomes were 
analysed by Nanosight tracking analysis. The second 
plasma samples (B) were aliquted and stored at - 80 ºC 
for three months. Exosomes were isolated, 
morphologically tested and analysed by NTA as 
prescribed below (preparation of plasma exosomes, 
and NTA).  
2.3.2 Preparation of Plasma Exosomes (Isolation and 
Extraction) 
Exosomes were isolated by differential 
ultracentrifugation. Basic exosome isolation protocols 
were followed as described [24]. A plasma sample was 
separated from blood by spinning whole blood at 1,000 g 
for 10 min in Biofuge primo ( Heraeus instrument). Then 
plasma was diluted with an equal amount of PBS (Sigma 
764) and gently mixed until homogenous. Then the 
mixture was transferred in 1,5 mL Eppendrof tubes, 
centrifuged for 30 min at 2,000× g, 4 °C (Biofuge 
 
 
fresco, Heraeus instrument). Then centrifuged at 12,000 
g for 45 min in a Beckman LE-80K centrifuge 
(Beckman Coulter Optima, swinging bucket rotors). 
The suspension was filtered through a 0.22-µm filter 
(pre-block with 1% BSA), collected in a fresh 
ultracentrifuge tube, and centrifuged for 2 h at 110,000× 
g, 4 °C in a Beckman LE-80K centrifuge (Beckman 
Coulter Optima, swinging bucket rotors). Subsequently 
the pellet was washed in PBS by filling the tube up to 
the top with PBS, and then centrifuged at 110,000× g, 4 
°C for 70 min (Beckman Coulter Optima, swinging 
bucket rotors). After, the pellets were re-suspended in 
50 µ PBS, and store d at -80 °C.  
2.3.3 ExoQuickTM Precipitation  
Exosome isolation from plasma ExoQuickTM 
precipitation was carried out according to 
manufacturer’s instructions (System Biosciences). 
Briefly, 500 mL of clarified CCM was diluted to 5 mL 
in PBS and mixed with 1 mL of ExoQuick-TCTM 
solution by inverting the tube several times. The sample 
was incubated overnight at 4 °C then centrifuged twice 
at 1,500 g for 30 and 5 min, respectively, in order to 
remove the supernatant. The supernatant was 
discarded, and the pellet was resuspended in 200 mL of 
PBS.  
2.3.4 Transmission Electron Microscopy (TEM) of 
Exosomes Samples 
An aliquot of exosomes vesicle sample was combined 
1:1 with 4% PFA (Sigma, 158127) and cooled for 15 min 
on ice. Then a single drop of each sample was placed onto 
a strip of Para film (VWR, 52858). Carbon-formvar 
coated copper grids, 200 mesh (F077, TAAB) were placed 
dull-side down onto the exosomes vesicles/PFA drop and 
left at room temperature for 30-45 min. Grids were then 
placed sample down onto three 30 μl drops of 0.22 μm 
filtered ultrapure water for one minute each. the side of the 
grids were gently touched to a filter paper between each 
drop to remove excess solution. Then grids were placed 
sample-side down onto a 30 μL drop of 2% uranyl acetate 
(aq) for two minutes. All grids were 
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Fig. 2 NTA measurement of particle size and concentration. 
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(a) (b)  
Fig. 3 A. fresh exosomes shown by electron microscopy, B. Frozen exosomes. 
 
touched to the filter paper and left to dry, in which 
sample side up for one hour. After that, grids were 
stored in a box for analysis by using a Hitachi H7650 
Transmission Electron Microscope (TEM) at 120 kV. 
 
2.3.5 Nanoparticle Tracking Analysis (NTA) 
Sample suspensions containing exosome vesicles 
were first diluted 1:500 PBS, kept on ice, then analysed 
using a Nanosight LM10, NS500 instrument 
(NanoSight, Amesbury, UK). For this, 90 second 
videos were used to track the Brownian movement 
using Version 2.2 Nanosight software to give mean and 
median vesicle size and concentration (Fig. 2). For 
every sample this reading was done five times with 
mixing in between and then an average taken to remove 
sample mixing bias. 
 
2.4 Statistical Analysis 
 
Participant’s characteristics data are presented as 
mean ± standard deviation (SD). Statistical analyses 
were completed in SPSS for windows version 21 
 
 
(SPSS Inc., Chicago, IL, USA). All variables were 
examined with one-way repeated measures ANOVA 
with time as the independent variable to detect any 
differences within day (time points 0 h, 1 h, 2 h, 3 h, 4 
h, 5 h, 6 h, 8 h and 10 h) or between days (day 1, 2, 3, 4 
and 5). Within day (across all nine time points; 0 h, 1 h, 
2 h, 3 h, 4 h, 5 h, 6 h, 8 h and 10 h) and between day 
(across all five visits) reliability were examined with a 
two-way mixed effect models interclass correlation 
coefficient (ICC3,1) for absolute agreement [25]. The 
ICC 95% confidence intervals (95% CI) were also 
calculated. An ICC ≥ 0.7 was accepted as moderate 
reliable as 0.6-0.8 considered as moderate reliability 
and ≥ 0.8 as good reliability. Coefficient of variation 
(CV) was determined for each participant using the 
formula: SD/mean  100 to determine measurement 
variability. Within day CVs were calculated across the 
time points. Within sample and between day CVs were 
calculated across the five visits and with the group 









3.1 Stability of Plasma Exosomes 
 
In order to assess the stability of plasma exosomes 
under different conditions, fresh and frozen plasma 
exosomes were isolated by differential 
ultracentrifugation as described above. Then they were 
analysed by NTA showed a particle size ranging from 
30 to 300 nm in diameter with an average of 120 
± 70 nm. The number of fresh and frozen plasma exosome 
was stable (fresh samples 3.68 ± 3.1, frozen samples 4.36 
± 2.8), there was no significant change between fresh and 
frozen plasma exosomes (P = 0.072) in all eleven samples 
which also analysed by NTA (Fig. 2). Under the electron 
microscopy, exosomes were appeared as spherical 
vesicles with a cup shape, also their diameters ranging 
from 30 to 120 nm (Fig. 3).  
Reliability of plasma exosomes measures within  
  
sample, within day, and between days  
This study was conducted to assess within and 
between day reliability of plasma exosomes 
concentration in healthy individuals. Eleven healthy 
men were assessed for reliability of exosome 
concentrations taken over the same sampling period, 
over 10 hours of a day and over five days. Table 1 
shows the descriptive characteristics of all the eleven 
subjects who completed the study. No one had reported 
of any illness in the 24 h prior to the blood draw. All 
subjects were non-smokers.  
Reliability and variability of plasma exosome 
concentration within the same subject at a single time 
point 
Within sample variability of blood plasma exosomes 
concentration in three different samples withdrawn 
consecutively from each subject was measured using 
the nanosight. 
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Fig 2 shows the number of exosomes which were measured under different conditions (fresh and frozen sample). 
 
Table 1 Subjects characteristics.  
 Number of subjects 11 
 Age (years) 27.6 ± 4.2 
 Height (cm) 177.2 ± 9.4 
 Weight (kg) 80.3 ± 12 
 Blood pressure (mm Hg) 130/73 ± 7.37 
 Heart rate (beat/min) 90 ± 30  
*Data is reported as mean ± standard deviation (SD). 
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Table 2 Within sample, between and within day measures of plasma exosomes concentration.  
  ANOVA 
ICC 
95% CONFIDENCE Coefficient of variation 
 
  P VALUE INTERVALS (CI) (CV) %     
 
 Within Sample 0.67 0.88 0.24-0.9 42 
 
 Between Day 0.42 0.84 0.827-0.926 34 
 
 Within Day 0.95 0.75 0.457-0.924 30 
  
CV showed as SD/Mean  100.  
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Fig. 2 Plasma exosome concentration of nine samples within one day over many hours showing the average of eleven 
participant samples, each replicate was measured five times on the Nanosight ( represented as mean ± standard deviation). 
 
The results from single level (sample-variation) of a 
repeated measures ANOVA test was performed in this 
study show that there was no significant difference 
between the three different repetitions of blood 
collection (P = 0.676). The reliability of plasma 
exosomes measures showed good within samples 
reliability (ICCs ≥ 0.88) and minimal variability within 
sample (Coefficient of variation CV = 42) (Table 2). 
Therefore, our results show good and reliable results in 
plasma exosomes concentration within consecutive 
samples.  
Reliability and variability of plasma exosome 
concentration and size within the same subject at 
multiple time points of the day 
To assess within day reliability of exosomes 
concentration we measured plasma vesicles over 10 
hours from each subject. The size distribution for 
exosomes was also measured within a day at different 
  
time points and also between days over five consecutive 
days in healthy individuals. 
A single level repeated measures ANOVA test was 
performed in this study. The results show that there was 
no significant differences at any time point (P = 0.95). 
The average exosomes values were 2.24 × 10^8/mL for 
all time points in all subjects (represented in Fig. 2). 
Moreover, the reliability of within day plasma 
exosomes measures showed a moderate reliability 
(ICCs ≥ 0.75, CV = 34%). For size distribution, the 
results shows that there was no change in the average 
size distribution at any time point of the day (P = 
0.014).  
Reliability and variability of plasma exosome 
concentration and size over multiple days 
The reliability and variability of plasma exosomes 
measures can be seen in Table 2, demonstrated good 
reliable measure of plasma exosome (ICCs ≥ 0.84) 
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Table 2 Exosome concentration represented as mean ± standard deviation of averages of eleven subjects per each day over five 
consecutive days. 
  Mean ± SD P value 
 Number of subjects 11  
 Average D1 1.52 ± 0.74 P = 0.64 
 Average D2 1.58 ± 0.96 P = 0.63 
 Average D3 2.53 ± 2.37 P = 0.67 
 Average D4 1.42 ± 0.84 P = 0.57 
 Average D5 1.94 ± 1.88 P =0.50  
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Fig. 3 Plasma exosome concentrations taken from the average of eleven participant samples over five consecutive days, each 
replicate was measured five times on the Nanosight (represented as mean ± standard deviation). 
 
And CV = 30). Over five days the average exosomes 
values of each sample were 1.505 ×10^8/mL. There 
was no significant difference in between day 
concentrations (P = 0.423). One-way analysis of 
variance (ANOVA) of the exosomes data also showed 
no significant effects differences between days 
(represented by the average value for each of the five 
days) is represented in Fig. 3. Moreover, there was no 
change in the average size distribution of all eleven 
subjects over the five consecutive days. These data 




In this study, we examined the within and between 
subject reliability of plasma exosome concentrations. 
As stated by Hopkins [26], that reliability refers to the 
  
reproducibility of values of a measurement in repeated 
trials on the same subject. However, Batterham and 
George [27] state that within subject variation, systemic 
change in the mean, and re-test correlations are the 
main measures of reliability. First, we examined the 
within sample reliability in three different samples 
withdrawn at the same time from each individual. There 
was no significant difference between the three 
different repetitions of blood collection (P > 0.05), 
which suggest that there is no significant variability 
explained by technical issues with blood sampling as it 
showed good reliability. Second, we examined the 
within day reliability through consequent measures of 
plasma exosomes over different time points (10 h 
monitoring). We found that there was no significant 
difference at any 
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time point, which suggests that exosomes are 
considerably stable within the day, also there was no 
significant differences between day measures. We found 
that average plasma exosomes concentration was ranged 
between 1.505-2.245 (vesicles × 10^8/mL). 
Our results are demonstrated that measurement of 
plasma exosomes concentration is reliable and 
repeatable in healthy subjects. The ICCs were ≥ 0.8 for 
within sample and between day measures, which shows 
good reliable measures of plasma exosomes 
concentration. Whereas ICCs of ≥ 0.75 was moderate 
for within day reliability. We also examined the stability 
of plasma exosomes under different conditions. Our 
results showed that freeze condition had no effect on 
size and number of plasma exosome. These results are 
consistent with Kalra, Adda [28], they assessed the 
stability of exosomes in plasma under various storage 
conditions and over 90 days. In which fresh and frozen 
plasma samples were obtained from five healthy donors 
and then blood plasma was pooled and prepared for 
exosomes isolation. Furthermore, a study conducted by 
[29] also tested the stability of exosomes during freeze 
thaw cycles, however plasma samples were collected 
from healthy pregnant women. Further to exosomes 
isolation by differential and sucrose density gradient 
centrifugation, they also measured common proteins 
identified in exosomes isolated from fresh plasma and 
after freeze/thaw cycles [29]. Exosomes are stable after 
a freeze and thaw cycle in healthy women during 
pregnancy. Recently, several studies investigated the 
stability of exosomes and also circulating miRNA from 
exsomes in plasma. It is therefore indicate that 
exosomes can be good biomarkers according to their 
stability under various conditions [29]. Finally we 
analysed plasma exosomes based on particle size. Data 
were divided into two categories, vesicles size ranges 
between 30-100 nm terms as exosomes and 
microvescicles for vesicles size ranged between 101-
1,000 nm. There was no change in the number of both 
extracellular vesicles. Also there was no 
 
 
significant change in exosomes size within the same 
subject at multiple time points of the day and over 
multiple days.  
There were several limitations which may contribute 
to increased variability in the measurement of plasma 
exosomes. First, there was no dietary control and 
dietary record for what they had in the day before. 
However, we attempted to control this by asking all the 
participants to be in a fasted state and by collecting the 
blood samples at the same time of each day over the 
five consecutive days. Second, the variability may be 
due to the number of physiological fluctuations which 
associated with an impairment of some immune 
parameter’s response [30]. Therefore, stress is one of 
the physiological factors that fluctuate from day to day 
which could be a possible cause for the variability in 
exosomes concentration over days. However, we 
attempted to minimise this by asking subjects to report 
to the laboratory in the same time every morning, in 
which blood collection was in rested state. Third, small 
sample size could be one of study limitations; however 




This study has assessed the within sample, within 
day and between day reliability of plasma exosomes 
concentration in healthy male individuals. We showed 
that exosomes isolated from blood plasma are reliable 
and can be a good indicator to search for vesicular 
biomarker. Also, we showed that freeze condition had 
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